|
þ
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended:
|
December 31, 2016
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
|
Wisconsin
(State or Other Jurisdiction
of Incorporation or Organization)
|
|
39-1506125
(I.R.S. Employer
Identification No.)
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
Common Stock, par value $0.01 per share
|
|
The NASDAQ Stock Market LLC
|
|
|
Page
|
PART I
|
|
|
|
|
|
Item 1.
|
||
|
|
|
Item 1A.
|
||
|
|
|
Item 1B.
|
||
|
|
|
Item 2.
|
||
|
|
|
Item 3.
|
||
|
|
|
Item 4.
|
||
|
|
|
|
||
|
|
|
PART II
|
|
|
|
|
|
Item 5.
|
||
|
|
|
Item 6.
|
||
|
|
|
Item 7.
|
||
|
|
|
Item 7A.
|
||
|
|
|
Item 8.
|
||
|
|
|
Item 9.
|
||
|
|
|
Item 9A.
|
||
|
|
|
Item 9B.
|
||
|
|
|
PART III
|
|
|
|
|
|
Item 10.
|
||
|
|
|
Item 11.
|
||
|
|
|
Item 12.
|
||
|
|
|
Item 13.
|
||
|
|
|
Item 14.
|
||
|
|
|
PART IV
|
|
|
|
|
|
Item 15.
|
||
|
|
|
Item 16.
|
||
|
|
|
|
•
|
Portfolio Management
. We expect to acquire businesses when we identify: a compelling strategic need, such as a product, service or technology that helps meet client demand; an opportunity to change industry dynamics; a way to achieve business scale; or similar considerations. We expect to divest businesses that are not in line with our market, product or financial strategies.
|
•
|
Client Relationship Value
. We plan to increase the number and breadth of our client relationships by, among other actions: continuing to integrate our products and services; introducing new products and services that are aligned with market needs; combining products and services to deliver enhanced, integrated value propositions; and improving the quality of our client service and support.
|
•
|
Operational Effectiveness
. We believe we can improve the quality of our client delivery while reducing our costs by using the opportunities created by our size and scale. For example, we are using our consolidated buying power and optimizing our facilities to create cost savings.
|
•
|
Capital Discipline
. We intend to make capital allocation decisions that offer the best prospects for our long-term growth and profitability, which may include, among other matters, internal investment, repayment of debt, repurchases of our own shares or acquisitions.
|
•
|
Innovation
. We seek to be an innovation leader, utilizing our assets and capabilities to be at the forefront of our industry and enable our clients to deliver best-in-class results.
|
Name
|
Age
|
Title
|
Jeffery W. Yabuki
|
56
|
President, Chief Executive Officer and Director
|
Mark A. Ernst
|
58
|
Chief Operating Officer
|
Kevin P. Gregoire
|
49
|
Group President, Financial Institutions Group
|
Robert W. Hau
|
51
|
Chief Financial Officer and Treasurer
|
Lynn S. McCreary
|
57
|
Chief Legal Officer and Secretary
|
Devin B. McGranahan
|
47
|
Group President, Billing and Payments Group
|
Kevin J. Schultz
|
59
|
Group President, Digital Banking Group
|
Steven Tait
|
57
|
Chief Sales Officer and Group President, International Group
|
Byron C. Vielehr
|
53
|
Group President, Depository Institution Services Group
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
|
2016
|
|
2015
|
||||||||||||
Quarter Ended
|
|
High
|
|
Low
|
|
High
|
|
Low
|
||||||||
March 31
|
|
$
|
102.88
|
|
|
$
|
85.63
|
|
|
$
|
80.97
|
|
|
$
|
69.13
|
|
June 30
|
|
108.85
|
|
|
96.34
|
|
|
86.39
|
|
|
76.92
|
|
||||
September 30
|
|
111.51
|
|
|
97.73
|
|
|
90.54
|
|
|
77.96
|
|
||||
December 31
|
|
109.11
|
|
|
92.81
|
|
|
97.76
|
|
|
85.41
|
|
Period
|
|
Total Number of
Shares Purchased
|
|
Average Price
Paid per Share
|
|
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs (1)
|
|
Maximum Number
of Shares that May
Yet Be Purchased
Under the Plans or
Programs (1)
|
|||||
October 1-31, 2016
|
|
1,168,000
|
|
|
$
|
99.31
|
|
|
1,168,000
|
|
|
6,914,000
|
|
November 1-30, 2016
|
|
806,000
|
|
|
101.63
|
|
|
806,000
|
|
|
21,108,000
|
|
|
December 1-31, 2016
|
|
630,000
|
|
|
106.19
|
|
|
630,000
|
|
|
20,478,000
|
|
|
Total
|
|
2,604,000
|
|
|
|
|
2,604,000
|
|
|
|
(1)
|
On each of November 18, 2015 and November 16, 2016, our board of directors authorized the purchase of up to 15.0 million shares of our common stock.
These authorizations do not expire.
|
|
December 31,
|
||||||||||||||||||||||
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
||||||||||||
Fiserv, Inc.
|
$
|
100
|
|
|
$
|
135
|
|
|
$
|
201
|
|
|
$
|
242
|
|
|
$
|
311
|
|
|
$
|
362
|
|
S&P 500 Index
|
100
|
|
|
116
|
|
|
154
|
|
|
175
|
|
|
177
|
|
|
198
|
|
||||||
NASDAQ US Benchmark Financial Administration Index
|
100
|
|
|
118
|
|
|
183
|
|
|
211
|
|
|
235
|
|
|
263
|
|
(In millions, except per share data)
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
||||||||||
Total revenue
|
$
|
5,505
|
|
|
$
|
5,254
|
|
|
$
|
5,066
|
|
|
$
|
4,814
|
|
|
$
|
4,436
|
|
Income from continuing operations
|
$
|
930
|
|
|
$
|
712
|
|
|
$
|
754
|
|
|
$
|
650
|
|
|
$
|
592
|
|
(Loss) income from discontinued operations
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
19
|
|
|||||
Net income
|
$
|
930
|
|
|
$
|
712
|
|
|
$
|
754
|
|
|
$
|
648
|
|
|
$
|
611
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss) per share - basic:
|
|
|
|
|
|
|
|
|
|
||||||||||
Continuing operations
|
$
|
4.22
|
|
|
$
|
3.04
|
|
|
$
|
3.04
|
|
|
$
|
2.48
|
|
|
$
|
2.18
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.01
|
)
|
|
0.07
|
|
|||||
Total
|
$
|
4.22
|
|
|
$
|
3.04
|
|
|
$
|
3.03
|
|
|
$
|
2.47
|
|
|
$
|
2.25
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss) per share - diluted:
|
|
|
|
|
|
|
|
|
|
||||||||||
Continuing operations
|
$
|
4.15
|
|
|
$
|
2.99
|
|
|
$
|
2.99
|
|
|
$
|
2.44
|
|
|
$
|
2.15
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
—
|
|
|
(0.01
|
)
|
|
0.07
|
|
|||||
Total
|
$
|
4.15
|
|
|
$
|
2.99
|
|
|
$
|
2.98
|
|
|
$
|
2.44
|
|
|
$
|
2.22
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total assets
|
$
|
9,743
|
|
|
$
|
9,340
|
|
|
$
|
9,308
|
|
|
$
|
9,466
|
|
|
$
|
8,542
|
|
Long-term debt (including current maturities)
|
4,562
|
|
|
4,293
|
|
|
3,790
|
|
|
3,831
|
|
|
3,213
|
|
|||||
Shareholders’ equity
|
2,541
|
|
|
2,660
|
|
|
3,295
|
|
|
3,585
|
|
|
3,417
|
|
•
|
Overview
. This section contains background information on our company and the services and products that we provide, our enterprise priorities and the trends affecting our industry in order to provide context for management’s discussion and analysis of our financial condition and results of operations.
|
•
|
Critical accounting policies and estimates
. This section contains a discussion of the accounting policies that we believe are important to our financial condition and results of operations and that require judgment and estimates on the part of management in their application. In addition, all of our significant accounting policies, including critical accounting policies, are summarized in Note 1 to the accompanying consolidated financial statements.
|
•
|
Results of operations
. This section contains an analysis of our results of operations presented in the accompanying consolidated statements of income by comparing the results for the year ended
December 31, 2016
to the results for the year ended
December 31, 2015
and by comparing the results for the year ended
December 31, 2015
to the results for the year ended
December 31, 2014
.
|
•
|
Liquidity and capital resources
. This section provides an analysis of our cash flows and a discussion of our outstanding debt and commitments at
December 31, 2016
.
|
(1)
|
Percentage of revenue is calculated as the relevant revenue, expense, income or loss amount divided by total revenue, except for cost of processing and services and cost of product amounts which are divided by the related component of revenue.
|
(In millions)
Year ended December 31,
|
Payments
|
|
Financial
|
|
Corporate
and Other
|
|
Total
|
|||||||||||
Total revenue:
|
|
|
|
|
|
|
|
|
|
|
||||||||
2016
|
$
|
3,090
|
|
|
|
$
|
2,477
|
|
|
|
$
|
(62
|
)
|
|
$
|
5,505
|
|
|
2015
|
2,862
|
|
|
|
2,443
|
|
|
|
(51
|
)
|
|
5,254
|
|
|
||||
2014
|
2,747
|
|
|
|
2,367
|
|
|
|
(48
|
)
|
|
5,066
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Revenue growth:
|
|
|
|
|
|
|
|
|
|
|
||||||||
2016
|
$
|
228
|
|
|
|
$
|
34
|
|
|
|
$
|
(11
|
)
|
|
$
|
251
|
|
|
2016 percentage
|
8
|
%
|
|
|
1
|
%
|
|
|
|
|
5
|
%
|
|
|||||
2015
|
$
|
115
|
|
|
|
$
|
76
|
|
|
|
$
|
(3
|
)
|
|
$
|
188
|
|
|
2015 percentage
|
4
|
%
|
|
|
3
|
%
|
|
|
|
|
4
|
%
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Operating income:
|
|
|
|
|
|
|
|
|
|
|
||||||||
2016
|
$
|
943
|
|
|
|
$
|
823
|
|
|
|
$
|
(321
|
)
|
|
$
|
1,445
|
|
|
2015
|
840
|
|
|
|
826
|
|
|
|
(355
|
)
|
|
1,311
|
|
|
||||
2014
|
768
|
|
|
|
773
|
|
|
|
(331
|
)
|
|
1,210
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Operating income growth:
|
|
|
|
|
|
|
|
|
|
|
||||||||
2016
|
$
|
103
|
|
|
|
$
|
(3
|
)
|
|
|
$
|
34
|
|
|
$
|
134
|
|
|
2016 percentage
|
12
|
%
|
|
|
—
|
%
|
|
|
|
|
10
|
%
|
|
|||||
2015
|
$
|
72
|
|
|
|
$
|
53
|
|
|
|
$
|
(24
|
)
|
|
$
|
101
|
|
|
2015 percentage
|
9
|
%
|
|
|
7
|
%
|
|
|
|
|
8
|
%
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Operating margin:
|
|
|
|
|
|
|
|
|
|
|
||||||||
2016
|
30.5
|
%
|
|
|
33.2
|
%
|
|
|
|
|
26.2
|
%
|
|
|||||
2015
|
29.3
|
%
|
|
|
33.8
|
%
|
|
|
|
|
24.9
|
%
|
|
|||||
2014
|
28.0
|
%
|
|
|
32.6
|
%
|
|
|
|
|
23.9
|
%
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Operating margin growth:
(1)
|
|
|
|
|
|
|
|
|
|
|
||||||||
2016
|
120
|
|
bps
|
|
(60
|
)
|
bps
|
|
|
|
130
|
|
bps
|
|||||
2015
|
130
|
|
bps
|
|
120
|
|
bps
|
|
|
|
100
|
|
bps
|
(1)
|
Represents the basis point growth or decline in operating margin.
|
|
December 31,
|
||||||
(In millions)
|
2016
|
|
2015
|
||||
Revolving credit facility
|
$
|
647
|
|
|
$
|
379
|
|
Term loan
|
629
|
|
|
628
|
|
||
2.7% senior notes due 2020
|
845
|
|
|
843
|
|
||
4.625% senior notes due 2020
|
448
|
|
|
448
|
|
||
4.75% senior notes due 2021
|
398
|
|
|
397
|
|
||
3.5% senior notes due 2022
|
695
|
|
|
694
|
|
||
3.85% senior notes due 2025
|
893
|
|
|
893
|
|
||
Other borrowings
|
7
|
|
|
11
|
|
||
Long-term debt (including current maturities)
|
$
|
4,562
|
|
|
$
|
4,293
|
|
(In millions)
|
|
Total
|
|
Less than
1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than
5 years
|
||||||||||
Long-term debt including interest
(1) (2)
|
|
$
|
5,297
|
|
|
$
|
241
|
|
|
$
|
818
|
|
|
$
|
2,513
|
|
|
$
|
1,725
|
|
Minimum operating lease payments
(1)
|
|
424
|
|
|
107
|
|
|
159
|
|
|
63
|
|
|
95
|
|
|||||
Purchase obligations
(1)
|
|
411
|
|
|
226
|
|
|
163
|
|
|
22
|
|
|
—
|
|
|||||
Income tax obligations
|
|
45
|
|
|
9
|
|
|
20
|
|
|
12
|
|
|
4
|
|
|||||
Total
|
|
$
|
6,177
|
|
|
$
|
583
|
|
|
$
|
1,160
|
|
|
$
|
2,610
|
|
|
$
|
1,824
|
|
(1)
|
Interest, operating lease and purchase obligations are reported on a pre-tax basis.
|
(2)
|
The calculations assume that only mandatory debt repayments are made, no additional refinancing or lending occurs, and the variable rates on the revolving credit facility and term loan are priced at the rate in effect as of December 31,
2016
.
|
|
Page
|
In millions, except per share data
Year ended December 31,
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
Revenue:
|
|
|
|
|
|
|
||||||
Processing and services
|
|
$
|
4,625
|
|
|
$
|
4,411
|
|
|
$
|
4,219
|
|
Product
|
|
880
|
|
|
843
|
|
|
847
|
|
|||
Total revenue
|
|
5,505
|
|
|
5,254
|
|
|
5,066
|
|
|||
Expenses:
|
|
|
|
|
|
|
||||||
Cost of processing and services
|
|
2,212
|
|
|
2,178
|
|
|
2,164
|
|
|||
Cost of product
|
|
747
|
|
|
731
|
|
|
717
|
|
|||
Selling, general and administrative
|
|
1,101
|
|
|
1,034
|
|
|
975
|
|
|||
Total expenses
|
|
4,060
|
|
|
3,943
|
|
|
3,856
|
|
|||
Operating income
|
|
1,445
|
|
|
1,311
|
|
|
1,210
|
|
|||
Interest expense
|
|
(163
|
)
|
|
(170
|
)
|
|
(164
|
)
|
|||
Interest and investment (loss) income, net
|
|
(7
|
)
|
|
1
|
|
|
1
|
|
|||
Loss on early debt extinguishment
|
|
—
|
|
|
(85
|
)
|
|
—
|
|
|||
Income from continuing operations before income taxes and income from investment in unconsolidated affiliate
|
|
1,275
|
|
|
1,057
|
|
|
1,047
|
|
|||
Income tax provision
|
|
(492
|
)
|
|
(377
|
)
|
|
(384
|
)
|
|||
Income from investment in unconsolidated affiliate
|
|
147
|
|
|
32
|
|
|
91
|
|
|||
Income from continuing operations
|
|
930
|
|
|
712
|
|
|
754
|
|
|||
Income (loss) from discontinued operations, net of income taxes
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Net income
|
|
$
|
930
|
|
|
$
|
712
|
|
|
$
|
754
|
|
|
|
|
|
|
|
|
||||||
Net income per share - basic:
|
|
|
|
|
|
|
||||||
Continuing operations
|
|
$
|
4.22
|
|
|
$
|
3.04
|
|
|
$
|
3.04
|
|
Discontinued operations
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Total
|
|
$
|
4.22
|
|
|
$
|
3.04
|
|
|
$
|
3.03
|
|
Net income per share - diluted:
|
|
|
|
|
|
|
||||||
Continuing operations
|
|
$
|
4.15
|
|
|
$
|
2.99
|
|
|
$
|
2.99
|
|
Discontinued operations
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Total
|
|
$
|
4.15
|
|
|
$
|
2.99
|
|
|
$
|
2.98
|
|
|
|
|
|
|
|
|
||||||
Shares used in computing net income per share:
|
|
|
|
|
|
|
||||||
Basic
|
|
220.3
|
|
|
233.9
|
|
|
248.6
|
|
|||
Diluted
|
|
223.9
|
|
|
238.0
|
|
|
252.7
|
|
In millions
Year ended December 31,
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
Net income
|
|
$
|
930
|
|
|
$
|
712
|
|
|
$
|
754
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
|
||||||
Reclassification adjustment for net realized losses on cash flow hedges included in interest expense, net of income tax provision of $5 million, $6 million and $6 million
|
|
7
|
|
|
10
|
|
|
8
|
|
|||
Foreign currency translation
|
|
(9
|
)
|
|
(21
|
)
|
|
(11
|
)
|
|||
Total other comprehensive loss
|
|
(2
|
)
|
|
(11
|
)
|
|
(3
|
)
|
|||
Comprehensive income
|
|
$
|
928
|
|
|
$
|
701
|
|
|
$
|
751
|
|
In millions
December 31,
|
|
2016
|
|
2015
|
||||
|
|
|
|
|
||||
Assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
300
|
|
|
$
|
275
|
|
Trade accounts receivable, less allowance for doubtful accounts
|
|
902
|
|
|
802
|
|
||
Prepaid expenses and other current assets
|
|
526
|
|
|
429
|
|
||
Total current assets
|
|
1,728
|
|
|
1,506
|
|
||
Property and equipment, net
|
|
405
|
|
|
396
|
|
||
Intangible assets, net
|
|
1,833
|
|
|
1,872
|
|
||
Goodwill
|
|
5,373
|
|
|
5,200
|
|
||
Other long-term assets
|
|
404
|
|
|
366
|
|
||
Total assets
|
|
$
|
9,743
|
|
|
$
|
9,340
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
|
||||
Accounts payable and accrued expenses
|
|
$
|
1,242
|
|
|
$
|
1,024
|
|
Current maturities of long-term debt
|
|
95
|
|
|
5
|
|
||
Deferred revenue
|
|
483
|
|
|
473
|
|
||
Total current liabilities
|
|
1,820
|
|
|
1,502
|
|
||
Long-term debt
|
|
4,467
|
|
|
4,288
|
|
||
Deferred income taxes
|
|
762
|
|
|
726
|
|
||
Other long-term liabilities
|
|
153
|
|
|
164
|
|
||
Total liabilities
|
|
7,202
|
|
|
6,680
|
|
||
Commitments and Contingencies
|
|
|
|
|
||||
Shareholders’ Equity
|
|
|
|
|
||||
Preferred stock, no par value: 25.0 million shares authorized; none issued
|
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value: 900.0 million shares authorized; 395.7 million shares issued
|
|
4
|
|
|
4
|
|
||
Additional paid-in capital
|
|
1,020
|
|
|
952
|
|
||
Accumulated other comprehensive loss
|
|
(76
|
)
|
|
(74
|
)
|
||
Retained earnings
|
|
8,994
|
|
|
8,064
|
|
||
Treasury stock, at cost, 180.2 million and 170.4 million shares
|
|
(7,401
|
)
|
|
(6,286
|
)
|
||
Total shareholders’ equity
|
|
2,541
|
|
|
2,660
|
|
||
Total liabilities and shareholders’ equity
|
|
$
|
9,743
|
|
|
$
|
9,340
|
|
|
|
Common Stock
|
|
Additional
Paid-In
Capital
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Retained
Earnings
|
|
Treasury Stock
|
||||||||||||||||
In millions
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Balance at January 1, 2014
|
|
396
|
|
|
$
|
4
|
|
|
$
|
844
|
|
|
$
|
(60
|
)
|
|
$
|
6,598
|
|
|
139
|
|
|
$
|
(3,801
|
)
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
754
|
|
|
|
|
|
|
|
|||||
Other comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|||||
Share-based compensation
|
|
|
|
|
|
|
|
49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Shares issued under stock plans including income tax benefits
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
64
|
|
|||||
Purchases of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18
|
|
|
(1,158
|
)
|
|||||
Balance at December 31, 2014
|
|
396
|
|
|
4
|
|
|
897
|
|
|
(63
|
)
|
|
7,352
|
|
|
155
|
|
|
(4,895
|
)
|
|||||
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
712
|
|
|
|
|
|
|
|
|||||
Other comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
|||||
Share-based compensation
|
|
|
|
|
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Shares issued under stock plans including income tax benefits
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
|
|
|
|
|
(2
|
)
|
|
80
|
|
|||||
Purchases of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
(1,471
|
)
|
|||||
Balance at December 31, 2015
|
|
396
|
|
|
4
|
|
|
952
|
|
|
(74
|
)
|
|
8,064
|
|
|
170
|
|
|
(6,286
|
)
|
|||||
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
930
|
|
|
|
|
|
|
|
|||||
Other comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|||||
Share-based compensation
|
|
|
|
|
|
|
|
68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Shares issued under stock plans including income tax benefits
|
|
|
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
83
|
|
|||||
Purchases of treasury stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
(1,198
|
)
|
|||||
Balance at December 31, 2016
|
|
396
|
|
|
$
|
4
|
|
|
$
|
1,020
|
|
|
$
|
(76
|
)
|
|
$
|
8,994
|
|
|
180
|
|
|
$
|
(7,401
|
)
|
In millions
Year ended December 31,
|
|
2016
|
|
2015
|
|
2014
|
||||||
|
|
|
|
|
|
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
|
||||||
Net income
|
|
$
|
930
|
|
|
$
|
712
|
|
|
$
|
754
|
|
Adjustments to reconcile net income to net cash provided by operating activities from continuing operations:
|
|
|
|
|
|
|
||||||
Depreciation and other amortization
|
|
253
|
|
|
223
|
|
|
200
|
|
|||
Amortization of acquisition-related intangible assets
|
|
158
|
|
|
194
|
|
|
204
|
|
|||
Share-based compensation
|
|
68
|
|
|
65
|
|
|
49
|
|
|||
Excess tax benefits from share-based awards
|
|
(51
|
)
|
|
(38
|
)
|
|
(18
|
)
|
|||
Deferred income taxes
|
|
21
|
|
|
20
|
|
|
3
|
|
|||
Income from investment in unconsolidated affiliate
|
|
(147
|
)
|
|
(32
|
)
|
|
(91
|
)
|
|||
Dividends from unconsolidated affiliate
|
|
151
|
|
|
36
|
|
|
110
|
|
|||
Non-cash impairment charges
|
|
17
|
|
|
6
|
|
|
—
|
|
|||
Loss on early debt extinguishment
|
|
—
|
|
|
85
|
|
|
—
|
|
|||
Other operating activities
|
|
(2
|
)
|
|
(1
|
)
|
|
—
|
|
|||
Changes in assets and liabilities, net of effects from acquisitions:
|
|
|
|
|
|
|
||||||
Trade accounts receivable
|
|
(88
|
)
|
|
(2
|
)
|
|
(42
|
)
|
|||
Prepaid expenses and other assets
|
|
(68
|
)
|
|
(66
|
)
|
|
(39
|
)
|
|||
Accounts payable and other liabilities
|
|
178
|
|
|
148
|
|
|
168
|
|
|||
Deferred revenue
|
|
11
|
|
|
(4
|
)
|
|
9
|
|
|||
Net cash provided by operating activities from continuing operations
|
|
1,431
|
|
|
1,346
|
|
|
1,307
|
|
|||
Cash flows from investing activities:
|
|
|
|
|
|
|
||||||
Capital expenditures, including capitalization of software costs
|
|
(290
|
)
|
|
(359
|
)
|
|
(292
|
)
|
|||
Payments for acquisitions of businesses
|
|
(265
|
)
|
|
—
|
|
|
—
|
|
|||
Net (purchases of) proceeds from investments
|
|
(1
|
)
|
|
1
|
|
|
7
|
|
|||
Other investing activities
|
|
2
|
|
|
(2
|
)
|
|
(1
|
)
|
|||
Net cash used in investing activities from continuing operations
|
|
(554
|
)
|
|
(360
|
)
|
|
(286
|
)
|
|||
Cash flows from financing activities:
|
|
|
|
|
|
|
||||||
Debt proceeds
|
|
2,126
|
|
|
3,121
|
|
|
604
|
|
|||
Debt repayments, including redemption and other costs
|
|
(1,863
|
)
|
|
(2,707
|
)
|
|
(653
|
)
|
|||
Proceeds from issuance of treasury stock
|
|
79
|
|
|
71
|
|
|
53
|
|
|||
Purchases of treasury stock, including employee shares withheld for tax obligations
|
|
(1,245
|
)
|
|
(1,522
|
)
|
|
(1,148
|
)
|
|||
Excess tax benefits from share-based awards
|
|
51
|
|
|
38
|
|
|
18
|
|
|||
Other financing activities
|
|
—
|
|
|
(6
|
)
|
|
—
|
|
|||
Net cash used in financing activities from continuing operations
|
|
(852
|
)
|
|
(1,005
|
)
|
|
(1,126
|
)
|
|||
Net change in cash and cash equivalents from continuing operations
|
|
25
|
|
|
(19
|
)
|
|
(105
|
)
|
|||
Net cash flows to discontinued operations
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|||
Cash and cash equivalents, beginning balance
|
|
275
|
|
|
294
|
|
|
400
|
|
|||
Cash and cash equivalents, ending balance
|
|
$
|
300
|
|
|
$
|
275
|
|
|
$
|
294
|
|
(In millions)
|
Estimated
Useful Lives
|
|
2016
|
|
2015
|
||||
Land
|
—
|
|
$
|
19
|
|
|
$
|
19
|
|
Data processing equipment
|
3 to 5 years
|
|
697
|
|
|
662
|
|
||
Buildings and leasehold improvements
|
5 to 40 years
|
|
256
|
|
|
253
|
|
||
Furniture and equipment
|
5 to 8 years
|
|
179
|
|
|
171
|
|
||
|
|
|
1,151
|
|
|
1,105
|
|
||
Less: accumulated depreciation
|
|
|
(746
|
)
|
|
(709
|
)
|
||
Total
|
|
|
$
|
405
|
|
|
$
|
396
|
|
(In millions)
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Book
Value
|
||||||
2016
|
|
|||||||||||
Customer related intangible assets
|
|
$
|
2,200
|
|
|
$
|
1,043
|
|
|
$
|
1,157
|
|
Acquired software and technology
|
|
507
|
|
|
432
|
|
|
75
|
|
|||
Trade names
|
|
117
|
|
|
57
|
|
|
60
|
|
|||
Capitalized software development costs
|
|
641
|
|
|
233
|
|
|
408
|
|
|||
Purchased software
|
|
230
|
|
|
97
|
|
|
133
|
|
|||
Total
|
|
$
|
3,695
|
|
|
$
|
1,862
|
|
|
$
|
1,833
|
|
|
|
|
|
|
|
|
||||||
(In millions)
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Book
Value
|
||||||
2015
|
|
|||||||||||
Customer related intangible assets
|
|
$
|
2,155
|
|
|
$
|
922
|
|
|
$
|
1,233
|
|
Acquired software and technology
|
|
488
|
|
|
413
|
|
|
75
|
|
|||
Trade names
|
|
120
|
|
|
53
|
|
|
67
|
|
|||
Capitalized software development costs
|
|
575
|
|
|
199
|
|
|
376
|
|
|||
Purchased software
|
|
256
|
|
|
135
|
|
|
121
|
|
|||
Total
|
|
$
|
3,594
|
|
|
$
|
1,722
|
|
|
$
|
1,872
|
|
(In millions)
|
|
Payments
|
|
Financial
|
|
Total
|
||||||
Goodwill - December 31, 2014
|
|
$
|
3,440
|
|
|
$
|
1,769
|
|
|
$
|
5,209
|
|
Foreign currency adjustments
|
|
(3
|
)
|
|
(6
|
)
|
|
(9
|
)
|
|||
Goodwill - December 31, 2015
|
|
3,437
|
|
|
1,763
|
|
|
5,200
|
|
|||
Acquired goodwill
|
|
173
|
|
|
—
|
|
|
173
|
|
|||
Goodwill - December 31, 2016
|
|
$
|
3,610
|
|
|
$
|
1,763
|
|
|
$
|
5,373
|
|
(In millions)
|
|
2016
|
|
2015
|
||||
Trade accounts payable
|
|
$
|
110
|
|
|
$
|
74
|
|
Client deposits
|
|
409
|
|
|
330
|
|
||
Settlement obligations
|
|
305
|
|
|
224
|
|
||
Accrued compensation and benefits
|
|
184
|
|
|
196
|
|
||
Other accrued expenses
|
|
234
|
|
|
200
|
|
||
Total
|
|
$
|
1,242
|
|
|
$
|
1,024
|
|
(In millions)
|
|
Cash Flow
Hedges
|
|
Foreign
Currency
Translation
|
|
Other
|
|
Total
|
||||||||
Balance at December 31, 2015
|
|
$
|
(31
|
)
|
|
$
|
(41
|
)
|
|
$
|
(2
|
)
|
|
$
|
(74
|
)
|
Other comprehensive loss before reclassifications
|
|
—
|
|
|
(9
|
)
|
|
—
|
|
|
(9
|
)
|
||||
Amounts reclassified from accumulated other comprehensive loss
|
|
7
|
|
|
—
|
|
|
—
|
|
|
7
|
|
||||
Net current-period other comprehensive (loss) income
|
|
7
|
|
|
(9
|
)
|
|
—
|
|
|
(2
|
)
|
||||
Balance at December 31, 2016
|
|
$
|
(24
|
)
|
|
$
|
(50
|
)
|
|
$
|
(2
|
)
|
|
$
|
(76
|
)
|
(In millions)
|
|
Cash Flow
Hedges
|
|
Foreign
Currency
Translation
|
|
Other
|
|
Total
|
||||||||
Balance at December 31, 2014
|
|
$
|
(41
|
)
|
|
$
|
(20
|
)
|
|
$
|
(2
|
)
|
|
$
|
(63
|
)
|
Other comprehensive loss before reclassifications
|
|
—
|
|
|
(21
|
)
|
|
—
|
|
|
(21
|
)
|
||||
Amounts reclassified from accumulated other comprehensive loss
|
|
10
|
|
|
—
|
|
|
—
|
|
|
10
|
|
||||
Net current-period other comprehensive (loss) income
|
|
10
|
|
|
(21
|
)
|
|
—
|
|
|
(11
|
)
|
||||
Balance at December 31, 2015
|
|
$
|
(31
|
)
|
|
$
|
(41
|
)
|
|
$
|
(2
|
)
|
|
$
|
(74
|
)
|
(In millions)
|
|
2016
|
|
2015
|
|
2014
|
|||
Weighted-average common shares outstanding used for the calculation of net income per share - basic
|
|
220.3
|
|
|
233.9
|
|
|
248.6
|
|
Common stock equivalents
|
|
3.6
|
|
|
4.1
|
|
|
4.1
|
|
Weighted-average common shares outstanding used for the calculation of net income per share - diluted
|
|
223.9
|
|
|
238.0
|
|
|
252.7
|
|
(In millions)
|
|
2016
|
|
2015
|
|
2014
|
||||||
Interest paid
|
|
$
|
147
|
|
|
$
|
150
|
|
|
$
|
144
|
|
Income taxes paid
|
|
408
|
|
|
306
|
|
|
336
|
|
|||
Treasury stock purchases settled after the balance sheet date
|
|
10
|
|
|
15
|
|
|
19
|
|
(In millions)
|
|
2016
|
|
2015
|
||||
Revolving credit facility
|
|
$
|
647
|
|
|
$
|
379
|
|
Term loan
|
|
629
|
|
|
628
|
|
||
2.7% senior notes due 2020
|
|
845
|
|
|
843
|
|
||
4.625% senior notes due 2020
|
|
448
|
|
|
448
|
|
||
4.75% senior notes due 2021
|
|
398
|
|
|
397
|
|
||
3.5% senior notes due 2022
|
|
695
|
|
|
694
|
|
||
3.85% senior notes due 2025
|
|
893
|
|
|
893
|
|
||
Other borrowings
|
|
7
|
|
|
11
|
|
||
Total debt
|
|
4,562
|
|
|
4,293
|
|
||
Less: current maturities
|
|
(95
|
)
|
|
(5
|
)
|
||
Long-term debt
|
|
$
|
4,467
|
|
|
$
|
4,288
|
|
|
2016
|
|
2015
|
|
2014
|
|||
Statutory federal income tax rate
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
State income taxes, net of federal effect
|
2.9
|
%
|
|
1.8
|
%
|
|
2.6
|
%
|
Unconsolidated affiliate tax
|
4.2
|
%
|
|
1.1
|
%
|
|
3.4
|
%
|
Domestic production activities deduction
|
(3.0
|
)%
|
|
(2.1
|
)%
|
|
(4.1
|
)%
|
Other, net
|
(0.5
|
)%
|
|
(0.1
|
)%
|
|
(0.3
|
)%
|
Effective income tax rate
|
38.6
|
%
|
|
35.7
|
%
|
|
36.6
|
%
|
(In millions)
|
2016
|
|
2015
|
|
2014
|
||||||
Current:
|
|
|
|
|
|
||||||
Federal
|
$
|
402
|
|
|
$
|
315
|
|
|
$
|
331
|
|
State
|
53
|
|
|
31
|
|
|
40
|
|
|||
Foreign
|
16
|
|
|
11
|
|
|
10
|
|
|||
|
471
|
|
|
357
|
|
|
381
|
|
|||
Deferred:
|
|
|
|
|
|
||||||
Federal
|
21
|
|
|
22
|
|
|
(4
|
)
|
|||
State
|
5
|
|
|
(2
|
)
|
|
6
|
|
|||
Foreign
|
(5
|
)
|
|
—
|
|
|
1
|
|
|||
|
21
|
|
|
20
|
|
|
3
|
|
|||
Income tax provision
|
$
|
492
|
|
|
$
|
377
|
|
|
$
|
384
|
|
(In millions)
|
2016
|
|
2015
|
||||
Accrued expenses
|
$
|
48
|
|
|
$
|
49
|
|
Interest rate hedge contracts
|
16
|
|
|
20
|
|
||
Share-based compensation
|
57
|
|
|
51
|
|
||
Net operating loss and credit carry-forwards
|
85
|
|
|
102
|
|
||
Deferred revenue
|
26
|
|
|
49
|
|
||
Other
|
15
|
|
|
12
|
|
||
Subtotal
|
247
|
|
|
283
|
|
||
Valuation allowance
|
(35
|
)
|
|
(35
|
)
|
||
Total deferred tax assets
|
212
|
|
|
248
|
|
||
|
|
|
|
||||
Capitalized software development costs
|
(156
|
)
|
|
(142
|
)
|
||
Intangible assets
|
(681
|
)
|
|
(700
|
)
|
||
Property and equipment
|
(67
|
)
|
|
(68
|
)
|
||
Other
|
(44
|
)
|
|
(42
|
)
|
||
Total deferred tax liabilities
|
(948
|
)
|
|
(952
|
)
|
||
Total
|
$
|
(736
|
)
|
|
$
|
(704
|
)
|
(In millions)
|
2016
|
|
2015
|
||||
Noncurrent assets
|
$
|
26
|
|
|
$
|
22
|
|
Noncurrent liabilities
|
(762
|
)
|
|
(726
|
)
|
||
Total
|
$
|
(736
|
)
|
|
$
|
(704
|
)
|
(In millions)
|
2016
|
|
2015
|
|
2014
|
||||||
Unrecognized tax benefits - Beginning of year
|
$
|
54
|
|
|
$
|
55
|
|
|
$
|
60
|
|
Increases for tax positions taken during the current year
|
9
|
|
|
10
|
|
|
9
|
|
|||
Increases for tax positions taken in prior years
|
1
|
|
|
—
|
|
|
10
|
|
|||
Decreases for tax positions taken in prior years
|
(15
|
)
|
|
(10
|
)
|
|
(21
|
)
|
|||
Decreases for settlements
|
(2
|
)
|
|
(1
|
)
|
|
(1
|
)
|
|||
Lapse of the statute of limitations
|
(2
|
)
|
|
—
|
|
|
(2
|
)
|
|||
Unrecognized tax benefits - End of year
|
$
|
45
|
|
|
$
|
54
|
|
|
$
|
55
|
|
|
2016
|
|
2015
|
|
2014
|
|||
Expected life (in years)
|
6.4
|
|
|
6.4
|
|
|
6.3
|
|
Average risk-free interest rate
|
1.9
|
%
|
|
1.9
|
%
|
|
2.0
|
%
|
Expected volatility
|
29.3
|
%
|
|
29.2
|
%
|
|
29.6
|
%
|
Expected dividend yield
|
0
|
%
|
|
0
|
%
|
|
0
|
%
|
|
Shares
(In thousands)
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual
Term (Years)
|
|
Aggregate
Intrinsic
Value
(In millions)
|
|||||
Stock options outstanding - December 31, 2015
|
8,589
|
|
|
$
|
40.00
|
|
|
|
|
|
||
Granted
|
1,010
|
|
|
97.07
|
|
|
|
|
|
|||
Forfeited
|
(105
|
)
|
|
80.34
|
|
|
|
|
|
|||
Exercised
|
(1,751
|
)
|
|
35.02
|
|
|
|
|
|
|||
Stock options outstanding - December 31, 2016
|
7,743
|
|
|
$
|
48.03
|
|
|
5.6
|
|
$
|
451
|
|
Stock options exercisable - December 31, 2016
|
5,667
|
|
|
$
|
35.32
|
|
|
4.5
|
|
$
|
402
|
|
|
|
Restricted Stock Units
|
|
Performance Share Units
|
||||||||||
|
|
Shares
(In thousands)
|
|
Weighted-
Average
Grant Date
Fair Value
|
|
Shares
(In thousands) |
|
Weighted-
Average Grant Date Fair Value |
||||||
Units - December 31, 2015
|
|
1,560
|
|
|
$
|
50.72
|
|
|
—
|
|
|
$
|
—
|
|
Granted
|
|
374
|
|
|
97.32
|
|
|
150
|
|
|
100.68
|
|
||
Forfeited
|
|
(78
|
)
|
|
68.18
|
|
|
(1
|
)
|
|
96.65
|
|
||
Vested
|
|
(592
|
)
|
|
45.09
|
|
|
—
|
|
|
—
|
|
||
Units - December 31, 2016
|
|
1,264
|
|
|
$
|
66.04
|
|
|
149
|
|
|
$
|
100.66
|
|
(In millions)
|
|
2016
|
|
2015
|
|
2014
|
||||||
Total intrinsic value of stock options exercised
|
|
$
|
113
|
|
|
$
|
123
|
|
|
$
|
43
|
|
Fair value of restricted stock units vested
|
|
58
|
|
|
41
|
|
|
35
|
|
|||
Income tax benefit from stock options exercised and restricted stock units vested
|
|
62
|
|
|
61
|
|
|
29
|
|
|||
Cash received from stock options exercised
|
|
39
|
|
|
35
|
|
|
33
|
|
(In millions)
|
Payments
|
|
Financial
|
|
Corporate
and Other
|
|
Total
|
||||||||
2016
|
|
|
|
|
|
|
|
||||||||
Processing and services revenue
|
$
|
2,334
|
|
|
$
|
2,285
|
|
|
$
|
6
|
|
|
$
|
4,625
|
|
Product revenue
|
756
|
|
|
192
|
|
|
(68
|
)
|
|
880
|
|
||||
Total revenue
|
3,090
|
|
|
2,477
|
|
|
(62
|
)
|
|
5,505
|
|
||||
Operating income
|
943
|
|
|
823
|
|
|
(321
|
)
|
|
1,445
|
|
||||
Total assets
|
6,143
|
|
|
3,287
|
|
|
313
|
|
|
9,743
|
|
||||
Capital expenditures
|
161
|
|
|
125
|
|
|
4
|
|
|
290
|
|
||||
Depreciation and amortization expense
|
138
|
|
|
89
|
|
|
184
|
|
|
411
|
|
||||
|
|
|
|
|
|
|
|
||||||||
2015
|
|
|
|
|
|
|
|
||||||||
Processing and services revenue
|
$
|
2,159
|
|
|
$
|
2,256
|
|
|
$
|
(4
|
)
|
|
$
|
4,411
|
|
Product revenue
|
703
|
|
|
187
|
|
|
(47
|
)
|
|
843
|
|
||||
Total revenue
|
2,862
|
|
|
2,443
|
|
|
(51
|
)
|
|
5,254
|
|
||||
Operating income
|
840
|
|
|
826
|
|
|
(355
|
)
|
|
1,311
|
|
||||
Total assets
|
5,833
|
|
|
3,242
|
|
|
265
|
|
|
9,340
|
|
||||
Capital expenditures
|
230
|
|
|
119
|
|
|
10
|
|
|
359
|
|
||||
Depreciation and amortization expense
|
119
|
|
|
76
|
|
|
222
|
|
|
417
|
|
||||
|
|
|
|
|
|
|
|
||||||||
2014
|
|
|
|
|
|
|
|
||||||||
Processing and services revenue
|
$
|
2,030
|
|
|
$
|
2,195
|
|
|
$
|
(6
|
)
|
|
$
|
4,219
|
|
Product revenue
|
717
|
|
|
172
|
|
|
(42
|
)
|
|
847
|
|
||||
Total revenue
|
2,747
|
|
|
2,367
|
|
|
(48
|
)
|
|
5,066
|
|
||||
Operating income
|
768
|
|
|
773
|
|
|
(331
|
)
|
|
1,210
|
|
||||
Total assets
|
5,850
|
|
|
3,225
|
|
|
233
|
|
|
9,308
|
|
||||
Capital expenditures
|
176
|
|
|
107
|
|
|
9
|
|
|
292
|
|
||||
Depreciation and amortization expense
|
102
|
|
|
71
|
|
|
231
|
|
|
404
|
|
(1)
|
During the first quarter of 2016, the Company recognized
$146 million
associated with its pre-tax share of a net gain on the sale of a business interest by StoneRiver, with related tax expense of
$54 million
. Refer to Note 3 for more information regarding the Company's investment in StoneRiver.
|
(2)
|
Net income per share in each period is calculated using actual, unrounded amounts.
|
(3)
|
In May 2015, the Company recorded a pre-tax loss on early debt extinguishment of
$85 million
associated with the redemption of certain of its senior notes funded from the proceeds of a public offering of senior notes. Refer to Note
4
for more information regarding the Company's long-term debt.
|
(a)
|
Disclosure Controls and Procedures
|
(b)
|
Management Report on Internal Control Over Financial Reporting
|
(c)
|
Changes in Internal Control Over Financial Reporting
|
(d)
|
Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting
|
(1)
|
Columns (a) and (c) of the table above do not include
1,189,096
unvested restricted stock units outstanding under the Fiserv, Inc. 2007 Omnibus Incentive Plan (the “Incentive Plan”) or
9,431,608
shares authorized for issuance under the Fiserv, Inc. Amended and Restated Employee Stock Purchase Plan. The number of shares remaining available for future issuance under the employee stock purchase plan is subject to an annual increase on the first day of each fiscal year equal to the lesser of (i) 2,000,000 shares, (ii) 1% of the shares of our common stock outstanding on such date or (iii) a lesser amount determined by our board of directors.
|
(2)
|
Consists of options outstanding under the Incentive Plan and the Fiserv, Inc. Stock Option and Restricted Stock Plan as well as
149,013
shares subject to performance share units at the target award level under the Incentive Plan and
75,309
shares subject to non-employee director deferred compensation notional units under the Incentive Plan.
|
(3)
|
Represents the weighted average exercise price of outstanding options and does not take into account outstanding performance share units or non-employee director deferred compensation notional units.
|
(4)
|
Reflects the number of shares available for future issuance under the Incentive Plan. No additional awards may be granted under the Fiserv, Inc. Stock Option and Restricted Stock Plan.
|
|
FISERV, INC.
|
|
|
|
|
|
By:
|
/s/ Jeffery W. Yabuki
|
|
|
Jeffery W. Yabuki
|
|
|
President and Chief Executive Officer
|
Name
|
|
Capacity
|
|
|
|
/s/ Daniel P. Kearney
|
|
Chairman of the Board
|
Daniel P. Kearney
|
|
|
|
|
|
/s/ Jeffery W. Yabuki
|
|
Director, President and Chief Executive Officer
(Principal Executive Officer)
|
Jeffery W. Yabuki
|
|
|
|
|
|
/s/ Robert W. Hau
|
|
Chief Financial Officer and Treasurer
(Principal Financial Officer)
|
Robert W. Hau
|
|
|
|
|
|
/s/ Kenneth F. Best
|
|
Chief Accounting Officer
(Principal Accounting Officer)
|
Kenneth F. Best
|
|
|
|
|
|
/s/ Alison Davis
|
|
Director
|
Alison Davis
|
|
|
|
|
|
/s/ John Kim
|
|
Director
|
John Kim
|
|
|
|
|
|
/s/ Dennis F. Lynch
|
|
Director
|
Dennis F. Lynch
|
|
|
|
|
|
/s/ Denis J. O’Leary
|
|
Director
|
Denis J. O’Leary
|
|
|
|
|
|
/s/ Glenn M. Renwick
|
|
Director
|
Glenn M. Renwick
|
|
|
|
|
|
/s/ Kim M. Robak
|
|
Director
|
Kim M. Robak
|
|
|
|
|
|
/s/ JD Sherman
|
|
Director
|
JD Sherman
|
|
|
|
|
|
/s/ Doyle R. Simons
|
|
Director
|
Doyle R. Simons
|
|
|
|
|
|
/s/ Thomas C. Wertheimer
|
|
Director
|
Thomas C. Wertheimer
|
|
|
Exhibit
Number
|
Exhibit Description
|
|
|
3.1
|
Restated Articles of Incorporation (1)
|
|
3.2
|
Amended and Restated By-laws (2)
|
|
4.1
|
Second Amended and Restated Credit Agreement, dated as of April 30, 2015, among Fiserv, Inc. and the financial institutions party thereto (3)
|
|
4.2
|
Loan Agreement, dated as of October 25, 2013, among Fiserv, Inc. and the financial institutions party thereto (4)
|
|
4.3
|
Amendment No. 1 to Loan Agreement, dated as of April 30, 2015, among Fiserv, Inc. and the financial institutions party thereto (3)
|
|
4.4
|
Indenture, dated as of November 20, 2007, by and among Fiserv, Inc., the guarantors named therein and U.S. Bank National Association (5)
|
|
4.5
|
Sixth Supplemental Indenture, dated as of September 21, 2010, among Fiserv, Inc., the guarantors named therein and U.S. Bank National Association (6)
|
|
4.6
|
Eighth Supplemental Indenture, dated as of June 14, 2011, among Fiserv, Inc., the guarantors named therein and U.S. Bank National Association (7)
|
|
4.7
|
Tenth Supplemental Indenture, dated as of September 25, 2012, among Fiserv, Inc., the guarantors named therein and U.S. Bank National Association (8)
|
|
4.8
|
Twelfth Supplemental Indenture, dated as of May 22, 2015, between Fiserv, Inc. and U.S. Bank National Association (9)
|
|
4.9
|
Thirteenth Supplemental Indenture, dated as of May 22, 2015, between Fiserv, Inc. and U.S. Bank National Association (9)
|
|
|
Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Company agrees to furnish to the Securities and Exchange Commission, upon request, any instrument defining the rights of holders of long-term debt that is not filed as an exhibit to this Form 10-K.
|
|
10.1
|
Fiserv, Inc. Amended and Restated 2007 Omnibus Incentive Plan (10)*
|
|
|
Fiserv, Inc. Amended and Restated 2007 Omnibus Incentive Plan Forms of Award Agreements
|
|
10.2
|
- Form of Restricted Stock Unit Agreement (Non‑Employee Director) (11)*
|
|
10.3
|
- Form of Restricted Stock Unit Agreement (Employee-PR)*
|
|
10.4
|
- Form of Amendment to Restricted Stock Unit Agreement (Employee-PR) (12)*
|
|
10.5
|
- Form of Restricted Stock Unit Agreement (Employee-E)*
|
|
10.6
|
- Form of Restricted Stock Unit Agreement (Employee-N)*
|
|
10.7
|
- Form of Non-Qualified Stock Option Agreement (Non-Employee Director) (11)*
|
|
10.8
|
- Form of Stock Option Agreement (Employee-F)*
|
|
10.9
|
- Form of Amendment to Stock Option Agreement (Employee-F) (12)*
|
|
10.10
|
- Form of Stock Option Agreement (Employee-E)*
|
|
10.11
|
- Form of Stock Option Agreement (Employee-N)*
|
|
10.12
|
- Form of Non-Qualified Stock Option Agreement (Special Equity Award 2008) (13)*
|
|
10.13
|
- Form of Performance Share Unit Agreement (Employee-PR)*
|
|
10.14
|
- Form of Performance Share Unit Agreement (Employee-E)*
|
|
10.15
|
- Form of Performance Share Unit Agreement (Employee-N)*
|
|
10.16
|
Amended and Restated Employment Agreement, dated December 22, 2008, between Fiserv, Inc. and Jeffery W. Yabuki (14)*
|
|
10.17
|
Amendment No. 1 to Amended and Restated Employment Agreement, dated February 26, 2009, between Fiserv, Inc. and Jeffery W. Yabuki (15)*
|
|
10.18
|
Amendment No. 2 to Amended and Restated Employment Agreement, dated December 30, 2009, between Fiserv, Inc. and Jeffery W. Yabuki (16)*
|
|
10.19
|
Amendment No. 3 to Amended and Restated Employment Agreement, dated March 29, 2016, between Fiserv, Inc. and Jeffery W. Yabuki (17)*
|
|
10.20
|
Amended and Restated Key Executive Employment and Severance Agreement, dated December 22, 2008, between Fiserv, Inc. and Jeffery W. Yabuki (14)*
|
|
10.21
|
Amendment No. 1 to Amended and Restated Key Executive Employment and Severance Agreement, dated March 29, 2016, between Fiserv, Inc. and Jeffery W. Yabuki (17)*
|
|
10.22
|
Employment Agreement, dated January 3, 2011, between Fiserv, Inc. and Mark A. Ernst (18)*
|
|
10.23
|
Employment Agreement, dated October 27, 2009, between Fiserv, Inc. and Steven Tait (19)*
|
|
10.24
|
Amendment No. 1 to Employment Agreement, dated December 11, 2009, between Fiserv, Inc. and Steven Tait (19)*
|
|
10.25
|
Employment Agreement, dated February 23, 2010, between Fiserv, Inc. and Lynn S. McCreary (20)*
|
|
10.26
|
Amendment No. 1 to Employment Agreement, dated July 1, 2013, between Fiserv, Inc. and Lynn S. McCreary (20)*
|
|
10.27
|
Employment Agreement, dated November 7, 2013, between Fiserv, Inc. and Byron C. Vielehr (10)*
|
|
10.28
|
Employment Agreement, dated May 21, 2014, between Fiserv, Inc. and Kevin P. Gregoire (21)*
|
|
10.29
|
Letter Agreement, dated October 22, 2014, between Fiserv, Inc. and Kevin J. Schultz (12)*
|
|
10.30
|
Form of Amended and Restated Key Executive Employment and Severance Agreement, between Fiserv, Inc. and each of Mark Ernst, Kevin Gregoire, Lynn McCreary, Kevin Schultz, Steven Tait and Byron Vielehr (14)*
|
|
10.31
|
Letter Agreement, effective February 10, 2016, between Fiserv, Inc. and Robert W. Hau (22)*
|
|
10.32
|
Form of Key Executive Employment and Severance Agreement between Fiserv, Inc. and Robert W. Hau (23)*
|
|
10.33
|
Letter Agreement, effective October 31, 2016, between Fiserv, Inc. and Devin B. McGranahan*
|
|
10.34
|
Key Executive Employment and Severance Agreement, dated October 31, 2016, between Fiserv, Inc. and Devin B. McGranahan*
|
|
10.35
|
Fiserv, Inc. Non-Qualified Deferred Compensation Plan*
|
|
10.36
|
Form of Non-Employee Director Indemnity Agreement (13)
|
|
10.37
|
Fiserv, Inc. Non-Employee Director Deferred Compensation Plan (13)*
|
|
10.38
|
Non-Employee Director Compensation Schedule (24)*
|
|
21.1
|
Subsidiaries of Fiserv, Inc.
|
|
23.1
|
Consent of Independent Registered Public Accounting Firm
|
|
31.1
|
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.2
|
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
|
32.1
|
Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS**
|
XBRL Instance Document
|
|
101.SCH**
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL**
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF**
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB**
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE**
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
**
|
Filed with this Annual Report on Form 10-K are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Income for the years ended December 31,
2016
,
2015
, and
2014
, (ii) the Consolidated Statements of Comprehensive Income for the years ended December 31,
2016
,
2015
, and
2014
, (iii) the Consolidated Balance Sheets at December 31,
2016
and
2015
, (iv) the Consolidated Statements of Shareholders’ Equity for the years ended December 31,
2016
,
2015
, and
2014
, (v) the Consolidated Statements of Cash Flows for the years ended December 31,
2016
,
2015
, and
2014
, and (vi) Notes to Consolidated Financial Statements.
|
(1)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on December 3, 2013, and incorporated herein by reference.
|
(2)
|
Previously filed as an exhibit to the Company’s Annual Report on Form 10-K filed on February 19, 2016, and incorporated herein by reference.
|
(3)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on May 5, 2015, and incorporated herein by reference.
|
(4)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on October 29, 2013, and incorporated herein by reference.
|
(5)
|
Previously filed as an exhibit to the Company’s Registration Statement on Form S-3 (File No. 333‑147309) filed on November 13, 2007, and incorporated herein by reference.
|
(6)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on September 21, 2010, and incorporated herein by reference.
|
(7)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on June 14, 2011, and incorporated herein by reference.
|
(8)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on September 25, 2012, and incorporated herein by reference.
|
(9)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on May 22, 2015, and incorporated herein by reference.
|
(10)
|
Previously filed as an exhibit to the Company’s Annual Report on Form 10-K filed on February 20, 2014, and incorporated herein by reference.
|
(11)
|
Previously filed as an exhibit to the Company’s Annual Report on Form 10-K filed on February 24, 2012, and incorporated herein by reference.
|
(12)
|
Previously filed as an exhibit to the Company’s Annual Report on Form 10-K filed on February 20, 2015, and incorporated herein by reference.
|
(13)
|
Previously filed as an exhibit to the Company’s Annual Report on Form 10-K filed on February 28, 2008, and incorporated herein by reference.
|
(14)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on December 23, 2008, and incorporated herein by reference.
|
(15)
|
Previously filed as an exhibit to the Company’s Annual Report on Form 10-K filed on February 27, 2009, and incorporated herein by reference.
|
(16)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on December 30, 2009, and incorporated herein by reference.
|
(17)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on April 1, 2016, and incorporated herein by reference.
|
(18)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on May 27, 2011, and incorporated herein by reference.
|
(19)
|
Previously filed as an exhibit to the Company’s Annual Report on Form 10-K filed on February 26, 2010, and incorporated herein by reference.
|
(20)
|
Previously filed as an exhibit to the Company’s Quarterly Report on Form 10-Q filed on October 30, 2013, and incorporated herein by reference.
|
(21)
|
Previously filed as an exhibit to the Company’s Quarterly Report on Form 10-Q filed on July 30, 2014, and incorporated herein by reference.
|
(22)
|
Previously filed as an exhibit to the Company’s Current Report on Form 8-K filed on February 16, 2016, and incorporated herein by reference.
|
(23)
|
Previously filed as an exhibit to the Company’s Quarterly Report on Form 10-Q filed on May 6, 2016, and incorporated herein by reference.
|
(24)
|
Previously filed as an exhibit to the Company’s Quarterly Report on Form 10-Q filed on July 30, 2015, and incorporated herein by reference.
|
|
|
|
Employee:
|
|
[FIRST NAME] [LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Number of Shares Subject to Award:
|
|
[NUMBER OF SHARES]
|
|
|
|
Vesting Schedule:
|
|
[
VESTING SCHEDULE
]
|
|
|
|
1.
|
Grant Date
.
The Award is granted to you on the Grant Date set forth in the Award Memorandum.
|
2.
|
Vesting
.
Provided that you are an employee as of the applicable date, this Award will vest as indicated in the Award Memorandum, and, subject to any deferral election then in effect, the Shares subject to this Award will be issued as indicated in this Agreement.
|
3.
|
Termination of Award
.
Your Award shall terminate in all events on the earlier of (a) the date upon which vesting is no longer permitted pursuant to Section 5 of this Agreement or (b) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
4.
|
Confidential Information; Non-Competition; Related Covenants
.
|
(a)
|
Definitions.
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is disclosed by you under order of law or governmental regulation; provided, however, that you agree to notify the General Counsel of Fiserv upon receipt of any request for disclosure as soon as possible prior to any such disclosure so that appropriate safeguards may be maintained.
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 4, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You agree to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or, where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either negotiating with Fiserv involving a Competing Product or Service, or concerning a potential or existing business or legal dispute with Fiserv, including, but not limited to, litigation, except as may be required by law.
|
(d)
|
You acknowledge and agree that compliance with this Section 4 is necessary to protect the Company, and that a breach of any of this Section 4 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 4, or any part thereof, the Company, and its successors and assigns, shall
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
(a)
|
Vesting.
If you cease to be an employee of the Company or any subsidiary of the Company for any reason (a “
Termination Event
”), the unvested portion of the Award shall terminate on the date on which such Termination Event occurs;
provided that
, if the reason for your Termination Event is death, Disability or Retirement, then the number of Shares issuable under this Award as of the date of your death, Disability or Retirement, subject to any deferral election then in effect, shall be calculated as follows: (i) the total number of Shares subject to this Award divided by four
times
(ii) the number of Grant Date anniversaries that have occurred since the Grant Date
minus
(iii) the number of Shares already issued to you or deferred pursuant to the Award.
|
(b)
|
Change of Control.
If a Change of Control of the Company occurs, the provisions of Section 17(c) of the Plan shall apply to this Award. If the successor or purchaser in the Change of Control has assumed the Company’s obligations with respect to this Award or provided a substitute award as contemplated by Section 17(c)(i) of the Plan and, within 12 months following the occurrence of the Change of Control, you are terminated without Cause or you terminate your employment for Good Reason (as hereinafter defined), this Award or such substitute award shall become fully vested, and the provisions of Section 4 shall immediately cease to apply.
|
(c)
|
Service as Director.
For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
(d)
|
No Further Obligation
. The Company will have no further obligations to you under this Award if the Award terminates as provided herein.
|
6.
|
Deferral of Restricted Stock Units
. If you are eligible to, and properly elect to, defer delivery of all or part of the Shares otherwise issuable under this Award, such deferral will be governed by the Restricted Stock Unit Deferral Election Form executed by you separately from this Agreement.
|
7.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Shares to you as soon as practicable after the Award vests, or, if a deferral election was made, at the time specified in the Deferral Election Form; provided that, if no deferral election is in effect and vesting occurs as a result of your Retirement, the Shares will be delivered upon your separation from service within the meaning of Code Section 409A, or if you are a specified employee within the meaning of Code Section 409A, immediately following the six-month anniversary of the date of your separation from service. If you die before the Company has distributed any portion of the vested Shares, the Company will issue the Shares to your estate or in accordance with applicable laws of descent and distribution. The Shares will be issued and delivered in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to this Award or the Shares, (b) any applicable federal or state laws, and/or (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) or any stock exchange upon which the Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Shares to reference any of the foregoing restrictions.
|
8.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Shares have been issued under this Award, this Award and the Shares issuable hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Award, or of any right or privilege conferred hereby, contrary to the provisions of the Plan or of this Agreement, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, this Award and the rights and privileges conferred hereby shall immediately become null and void.
|
9.
|
Conditions to Issuance of Shares
. The Shares issued to you hereunder may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the date of vesting of the Award or the payment event specified in a deferral election as the Compensation Committee may establish from time to time for reasons of administrative convenience (provided that any such period shall be in compliance with Code Section
|
10.
|
Dividends; No Rights as Shareholder
.
If the Company declares a cash dividend and the dividend record date occurs prior to the date the Award vests, you will be credited with an additional number of Restricted Stock Units on the date the cash dividends are paid to the Company shareholders equal to (a) the amount of cash dividends payable with respect to a number of shares of stock equal to your Restricted Stock Units divided by (b) the Fair Market Value of a Share on the date the dividend is paid. These additional Restricted Stock Units will be subject to the same terms and conditions as the Restricted Stock Units with respect to which the dividend equivalents were credited. Until this Award vests and the Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Shares. Specifically, you understand and agree that you do not have voting rights or, except as provided in this Section 10, the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Award or the Shares subject hereto.
|
11.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
12.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
13.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement and any disposition of Shares and that upon the acquisition of any Shares subject to this Award, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences associated with the granting of the Award, the vesting of the Award, the deferral of all or a portion of the Shares otherwise issuable upon vesting of the Award, and the subsequent sale or other disposition of any Shares. You understand and agree that when this Award vests and Shares are issued, and you thereby realize gross income (if any) taxable as compensation in respect of such vesting or issuance, the Company will be required to withhold federal, state and local taxes on the full amount of the compensation income realized by you and may also be required to withhold other amounts as a result of such vesting. You hereby agree to provide the Company with cash funds or Shares equal in value to the federal, state and local taxes and other amounts required to be withheld by the Company or its subsidiary in respect of any compensation income in relation to the Award or make other arrangements satisfactory to the Company regarding such amounts. All matters with respect to the total amount to be withheld shall be determined by the Company in its sole discretion.
|
15.
|
General Provisions
.
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
(b)
|
This Agreement, the Award Memorandum, the Plan and the Restricted Stock Unit Deferral Election Form, if any, contain the entire agreement between the Company and you relating to the Award and the Shares and supersede all prior agreements or understandings relating thereto.
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the administrative agent’s website (
www.netbenefits.fidelity.com
) in the “forms library” and a paper copy is available upon request.
|
(h)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
(i)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind this Award and/or the Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME] [LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Number of Shares Subject to Award:
|
|
[NUMBER OF SHARES]
|
|
|
|
Date Vested:
|
|
[VESTING SCHEDULE]
|
1.
|
Grant Date
.
The Award is granted to you on the Grant Date set forth in the Award Memorandum.
|
2.
|
Vesting
.
Provided that you are an employee as of the applicable date, this Award will vest as indicated in the Award Memorandum, and, subject to any deferral election then in effect, the Shares subject to this Award will be issued as indicated in this Agreement. This Award also may continue to vest following your Retirement (as defined below) as described in Section 5(a).
|
3.
|
Termination of Award
. Your Award shall terminate in all events on the earlier of (a) the date upon which vesting is no longer permitted pursuant to Section 5 of this Agreement or (b) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
4.
|
Confidential Information; Non-Competition; Related Covenants
.
|
|
(a)
|
Definitions.
|
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is disclosed by you under order of law or governmental regulation; provided, however, that you agree to notify the General Counsel of Fiserv upon receipt of any request for disclosure as soon as possible prior to any such disclosure so that appropriate safeguards may be maintained.
|
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 4, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
|
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You agree to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.
|
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or, where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
|
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
|
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
|
You understand that if you are found to have wrongfully misappropriated a trade secret, you may be liable to the Company for, among other things, exemplary damages and attorneys’ fees.
|
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv (or, in the case of Retirement, for a period of 12 months following the later of (x) the date of the last restricted stock unit vesting event following Retirement or (y) the latest date upon which you are entitled to exercise an option following Retirement (in either case, assuming no Post-Retirement Violation)), you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either negotiating with Fiserv involving a Competing Product or Service, or concerning a potential or existing business or legal dispute with Fiserv, including, but not limited to, litigation, except as may be required by law.
|
|
(d)
|
You acknowledge and agree that compliance with this Section 4 is necessary to protect the Company, and that a breach of any of this Section 4 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 4, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 4, or to enjoin you from performing services in breach of Section 4(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
|
(e)
|
You further agree that, in the event of your breach of this Section 4, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
|
(g)
|
YOU HAVE READ THIS SECTION 4 AND SECTION 5(a)(ii)(F) AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
5.
|
Termination of Employment.
|
|
|
(a)
|
Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason (a “
Termination Event
”), the unvested portion of the Award shall terminate on the date on which such Termination Event occurs;
provided that
, if the reason for your Termination Event is:
(i)
death or Disability, then the number of Shares issuable under this Award as of the date of your death or Disability, subject to any deferral election then in effect, shall be calculated as follows: (A) the total number of Shares subject to this Award divided by four
times
(B) the number of Grant Date anniversaries that have occurred since the Grant Date
minus
(C) the number of Shares already issued to you or deferred pursuant to the Award;
(ii)
Retirement, then the unvested portion of the Award shall continue to vest on the dates indicated in the Award Memorandum as if you had not ceased to be an employee. Notwithstanding the foregoing:
(A) If you receive written notification from the Compensation Committee that you failed to provide for an orderly transition of your duties to a successor, then any portion of the Award that is unvested as of the date of such notification shall terminate as of such date.
(B) If, at any time following your Retirement, one of the following events occurs (a “
Post-Retirement Violation
”), then any portion of the Award that is unvested as of the date of such Post-Retirement Violation shall terminate as of the date such event occurs: (I) you commence employment of any kind (other than board or public service, work for a not-for-profit or de minimis for-profit employment); (II) you commence work of any kind for a Competitor, including as an employee, board member, consultant or otherwise; or (III) you violate any post-employment covenant applicable to you
|
|
|
under any agreement in effect with, or policy of, the Company or any of its subsidiaries, including without limitation those set forth in Section 4.
(C) If, while this Award is outstanding, you commence employment or other work of any kind following your Retirement, you are required to promptly provide written notice to the Company of the name of your employer and the nature of your position or other work.
(D) If you receive any benefit under this Award after the date of a Post-Retirement Violation, then you will be obligated to repay to the Company the value of such benefit (with such value to be determined by the Company, which may include a reasonable rate of interest) promptly following your receipt of notice of such repayment obligation from the Company.
(E) All determinations regarding whether you have engaged in a Post-Retirement Violation shall be made by the Compensation Committee.
(F) Without limiting any other provision of this Agreement, if a Post-Retirement Violation described in (ii)(B)(II) or (III) above occurs following Retirement, the Company shall be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
Notwithstanding the foregoing, if you die after Retirement and prior to the date the Award vests in full (and provided that a Post-Retirement Violation has not occurred), then the Award shall become fully vested as of the date of your death.
If you are regularly scheduled to work less than 20 hours per calendar week for the Company or any subsidiary of the Company, you will be deemed to have experienced a Termination Event.
|
|
(b)
|
Retirement
.
For purposes of this Section 5, “
Retirement
” means the cessation of service as an employee for any reason other than death, Disability or termination for Cause if:
(i) (A) you are at least 50 years of age and your age plus years of service to the Company and its subsidiaries is equal to or greater than 70 (with at least 5 years of continuous service to the Company and its subsidiaries immediately prior to such cessation of service) or (B) you are at least 55 years of age with at least 5 years of continuous service to the Company and its subsidiaries immediately prior to such cessation of service; and
(ii) you have provided for an orderly transition of your duties to a successor, including by: (A) providing notice to the Company’s Chief Executive Officer (or, if you are the Chief Executive Officer, to the Chairman of the Board of Directors) of your consideration of Retirement sufficiently in advance of your proposed date of Retirement; and (B) assisting with the identification and selection of, and transition of your duties to, a successor ((A) and (B) being referred to herein collectively as the “
Specified Transition Requirements
”).
If you meet the criteria in paragraph (i) above and you satisfy the Specified Transition Requirements, your cessation of service will be deemed to be a qualifying Retirement; provided that, the Compensation Committee may determine, within 30 days after your cessation of service, that you failed to provide for an orderly transition of your duties to a successor. By way of example only, this could result from providing too short of notice or not providing an adequate amount of transition assistance.
|
|
(c)
|
Change of Control
. If a Change of Control of the Company occurs, the provisions of Section 17(c) of the Plan shall apply to this Award. If the successor or purchaser in the Change of Control has assumed the Company’s obligations with respect to this Award or provided a substitute award as contemplated by Section 17(c)(i) of the Plan and, within 12 months following the occurrence of the Change of Control, you are terminated without Cause or you terminate your employment for Good Reason (as hereinafter defined), this Award or such substitute award shall become fully vested, and the provisions of Section 4 shall immediately cease to apply.
|
|
(d)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
|
(e)
|
No Further Obligation
. The Company will have no further obligations to you under this Award if the Award terminates as provided herein.
|
6.
|
Deferral of Restricted Stock Units
. If you are eligible to, and properly elect to, defer delivery of all or part of the Shares otherwise issuable under this Award, such deferral will be governed by the Restricted Stock Unit Deferral Election Form executed by you separately from this Agreement.
|
7.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Shares to you as soon as practicable after the Award vests (pursuant to the terms hereof) with respect to such Shares, or, if a deferral election was made, at the time specified in the Deferral Election Form; provided that, if the Award vests as a result of a Termination Event resulting from your Disability after you become Retirement-eligible, then the Shares will be delivered upon the next scheduled vesting date after your separation from service within the meaning of Code Section 409A. If you die before the Company has distributed any portion of the vested Shares, the Company will issue the Shares to your estate or in accordance with applicable laws of descent and distribution. The Shares will be issued and delivered in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to this Award or the Shares, (b) any applicable federal or state laws and (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) or any stock exchange upon which the Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Shares to reference any of the foregoing restrictions.
|
8.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Shares have been issued under this Award, this Award and the Shares
|
9.
|
Conditions to Issuance of Shares
. The Shares issued to you hereunder may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the date of vesting of the Award or the payment event specified in a deferral election as the Compensation Committee may establish from time to time for reasons of administrative convenience (provided that any such period shall be in compliance with Code Section 409A); and (e) your acceptance of the terms and conditions of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
10.
|
Dividends; No Rights as Shareholder
.
If the Company declares a cash dividend and the dividend record date occurs prior to the date the Award vests, you will be credited with an additional number of Restricted Stock Units on the date the cash dividends are paid to the Company shareholders equal to (a) the amount of cash dividends payable with respect to a number of shares of stock equal to your Restricted Stock Units divided by (b) the Fair Market Value of a Share on the date the dividend is paid. These additional Restricted Stock Units will be subject to the same terms and conditions as the Restricted Stock Units with respect to which the dividend equivalents were credited. Until this Award vests and the Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Shares. Specifically, you understand and agree that you do not have voting rights or, except as provided in this Section 10, the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Award or the Shares subject hereto.
|
11.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
12.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
13.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement and any disposition of Shares and that upon the acquisition of any Shares subject to this Award, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences associated with the granting of the Award, the vesting of the Award, the deferral of all or a portion of the Shares otherwise issuable upon vesting of the Award, and the subsequent sale or other disposition of any Shares. You understand and agree that when this Award vests and Shares are issued, and you thereby realize gross income (if any) taxable as compensation in respect of such vesting or issuance, the Company will be required to withhold federal, state and local taxes on the full amount of the compensation income realized by you and may also be required to withhold other amounts as a result of such vesting. You also understand and agree that the Company may be required to withhold certain payroll taxes in connection with your Retirement or your termination due to Disability prior to the issuance of Shares. You hereby agree to provide the Company with cash funds or Shares equal in value to the federal, state and local payroll and income taxes and other amounts required to be withheld by the Company or its subsidiary in respect of any compensation income or wages in relation to the Award or make other arrangements satisfactory to the Company regarding such amounts, which may include deduction of such taxes from other wages owed to you by the Company or its subsidiaries. All matters with respect to the total amount to be withheld shall be determined by the Company in its sole discretion.
|
14.
|
Market Stand-Off
. The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Award without the prior written consent of the Company. Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company. In no event, however, shall such period exceed one hundred eighty (180) days.
|
15.
|
General Provisions
.
|
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
|
(b)
|
This Agreement, the Award Memorandum, the Plan and the Restricted Stock Unit Deferral Election Form, if any, contain the entire agreement between the Company and you relating to the Award and the Shares and supersede all prior agreements or understandings relating thereto.
|
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the Company’s administrative agent’s website (www.netbenefits.fidelity.com) in the “forms library” and a paper copy is available upon request.
|
|
(h)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
|
(i)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind this Award and/or the Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME] [LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Number of Shares Subject to Award:
|
|
[NUMBER OF SHARES]
|
|
|
|
Date Vested:
|
|
[VESTING SCHEDULE]
|
1.
|
Grant Date
.
The Award is granted to you on the Grant Date set forth in the Award Memorandum.
|
2.
|
Vesting
.
Provided that you are an employee as of the applicable date, this Award will vest as indicated in the Award Memorandum, and, subject to any deferral election then in effect, the Shares subject to this Award will be issued as indicated in this Agreement.
|
3.
|
Termination of Award
. Your Award shall terminate in all events on the earlier of (a) the date upon which vesting is no longer permitted pursuant to Section 5 of this Agreement or (b) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
4.
|
Confidential Information; Non-Competition; Related Covenants
.
|
|
(a)
|
Definitions.
|
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is disclosed by you under order of law or governmental regulation; provided, however, that you agree to notify the General Counsel of Fiserv upon receipt of any request for disclosure as soon as possible prior to any such disclosure so that appropriate safeguards may be maintained.
|
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 4, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
|
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You agree to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.
|
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or, where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
|
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
|
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
|
You understand that if you are found to have wrongfully misappropriated a trade secret, you may be liable to the Company for, among other things, exemplary damages and attorneys’ fees.
|
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either negotiating with Fiserv involving a Competing Product or Service, or concerning a potential or existing business or legal dispute with Fiserv, including, but not limited to, litigation, except as may be required by law.
|
|
(d)
|
You acknowledge and agree that compliance with this Section 4 is necessary to protect the Company, and that a breach of any of this Section 4 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 4, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 4, or to enjoin you from performing services in breach of Section 4(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
|
(e)
|
You further agree that, in the event of your breach of this Section 4, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
|
(g)
|
YOU HAVE READ THIS SECTION 4 AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
5.
|
Termination of Employment
.
|
|
(a)
|
Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason (a “
Termination Event
”), the unvested portion of the Award shall terminate on the date on which such Termination Event occurs;
provided that
, if the reason for your Termination Event is death or Disability, then the number of Shares issuable under this Award as of the date of your death or Disability, subject to any deferral election then in effect, shall be calculated as follows: (i) the total number of Shares subject to this Award divided by four
times
(ii) the number of Grant Date anniversaries that have occurred since the Grant Date
minus
(iii) the number of Shares already issued to you or deferred pursuant to the Award. If you are regularly scheduled to work less than 20 hours per calendar week for the Company or any subsidiary of the Company, you will be deemed to have experienced a Termination Event.
|
|
|
|
|
(b)
|
Change of Control
. If a Change of Control of the Company occurs, the provisions of Section 17(c) of the Plan shall apply to this Award. If the successor or purchaser in the Change of Control has assumed the Company’s obligations with respect to this Award or provided a substitute award as contemplated by Section 17(c)(i) of the Plan and, within 12 months following the occurrence of the Change of Control, you are terminated without Cause or you terminate your employment for Good Reason (as hereinafter defined), this Award or such substitute award shall become fully vested, and the provisions of Section 4 shall immediately cease to apply.
|
|
(c)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
|
(d)
|
No Further Obligation
. The Company will have no further obligations to you under this Award if the Award terminates as provided herein.
|
6.
|
Deferral of Restricted Stock Units
. If you are eligible to, and properly elect to, defer delivery of all or part of the Shares otherwise issuable under this Award, such deferral will be governed by the Restricted Stock Unit Deferral Election Form executed by you separately from this Agreement.
|
7.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Shares to you as soon as practicable after the Award vests (pursuant to the terms hereof) with respect to such Shares, or, if a deferral election was made, at the time specified in the Deferral Election Form. If you die before the Company has distributed any portion of the vested Shares, the Company will issue the Shares to your estate or in accordance with applicable laws of descent and distribution. The Shares will be issued and delivered in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to this Award or the Shares, (b) any applicable federal or state laws and (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) or any stock exchange upon which the Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Shares to reference any of the foregoing restrictions.
|
8.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Shares have been issued under this Award, this Award and the Shares issuable hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Award, or of any right or privilege conferred hereby, contrary to the provisions of the Plan or of this Agreement, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, this Award and the rights and privileges conferred hereby shall immediately become null and void.
|
9.
|
Conditions to Issuance of Shares
. The Shares issued to you hereunder may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the date of vesting of the Award or the payment event specified in a deferral election as the Compensation Committee may establish from time to time for reasons of administrative convenience (provided that any such period shall be in compliance with Code Section 409A); and (e) your acceptance of the terms and conditions of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
10.
|
Dividends; No Rights as Shareholder
.
If the Company declares a cash dividend and the dividend record date occurs prior to the date the Award vests, you will be credited with an additional number of Restricted Stock Units on the date the cash dividends are paid to the Company shareholders equal to (a) the amount of cash dividends payable with respect to a number of shares of stock equal to your Restricted Stock Units divided by (b) the Fair Market Value of a Share on the date the dividend is paid. These additional Restricted Stock Units will be subject to the same terms and conditions as the Restricted Stock Units with respect to which the dividend equivalents were credited. Until this Award vests and the Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Shares. Specifically, you understand and agree that you do not have voting rights or, except as provided in this Section 10, the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Award or the Shares subject hereto.
|
11.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
12.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
13.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement and any disposition of Shares and that upon the acquisition of any Shares subject to this Award, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences associated with the granting of the Award, the vesting of the Award, the deferral of all or a portion of the Shares otherwise issuable upon vesting of the Award, and the subsequent sale or other disposition of any Shares. You understand and agree that when this Award vests and Shares are issued, and you thereby realize gross income (if any) taxable as compensation in respect of such vesting or issuance, the Company will be required to withhold federal, state and local taxes on the full amount of the compensation income realized by you and may also be required to withhold other amounts as a result of such vesting. You hereby agree to provide the Company with cash funds or Shares equal in value to the federal, state and local payroll and income taxes and other amounts required to be withheld by the Company or its subsidiary in respect of any compensation income or wages in relation to the Award or make other arrangements satisfactory to the Company regarding such amounts, which may include deduction of such taxes from other wages owed to you by the Company or its subsidiaries. All matters with respect to the total amount to be withheld shall be determined by the Company in its sole discretion.
|
14.
|
Market Stand-Off
. The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any
|
15.
|
General Provisions
.
|
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
|
(b)
|
This Agreement, the Award Memorandum, the Plan and the Restricted Stock Unit Deferral Election Form, if any, contain the entire agreement between the Company and you relating to the Award and the Shares and supersede all prior agreements or understandings relating thereto.
|
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the Company’s administrative agent’s website (www.netbenefits.fidelity.com) in the “forms library” and a paper copy is available upon request.
|
|
(h)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
|
(i)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind this Award and/or the Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME] [LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Number of Shares Subject to Option:
|
|
[NUMBER OF SHARES]
|
|
|
|
Exercise Price Per Option Share:
|
|
[EXERCISE PRICE]
|
|
|
|
Type of Option:
|
|
|
|
|
|
Vesting Schedule:
|
|
[VESTING SCHEDULE]
|
|
|
|
Expiration Date:
|
|
10 years after the Grant Date
|
1.
|
Grant Date; Type of Option
.
The Option is granted to you on the Grant Date set forth in the Award Memorandum. If the Option is designated as a “non-qualified stock option” in the Award Memorandum, then the Option will not be treated by you or the Company as an incentive stock option as defined in Section 422 of the Code. If the Option is designated as an “incentive stock option” in the Award Memorandum, then the Option is intended to satisfy the requirements of Section 422 of the Code.
|
2.
|
Termination of Option
.
Your right to exercise the Option and to purchase the Option Shares shall expire and terminate in all events on the earliest of (a) the Expiration Date set forth in the Award Memorandum or (b) the date upon which exercise is no longer permitted pursuant to Section 7 of this Agreement or (c) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
3.
|
Exercise Price
.
The purchase price to be paid upon the exercise of the Option will be the Exercise Price Per Option Share set forth in the Award Memorandum.
|
4.
|
Vesting;
Provisions Relating to Exercise
.
Once you become entitled to exercise any part of the Option (and to purchase Option Shares) pursuant to the vesting schedule set forth in the Award Memorandum, that right will continue until the date on which the Option expires and terminates. The right to purchase Option Shares under the Option is cumulative, so that if the full number of Option Shares is not purchased in a single transaction, the balance may be purchased at any time or from time to time thereafter during the term of the Option. The Administrator, in its sole discretion, may at any time accelerate the time at which the Option becomes exercisable by you with respect to any Option Shares. The Company may cancel, rescind, suspend, withhold or otherwise limit or restrict any unexpired, unpaid or deferred part of the Option at any time if you are not in compliance with all applicable provisions of this Agreement, the Award Memorandum and the Plan.
|
5.
|
Confidential Information, Non-Competition and Related Covenants
.
|
(a)
|
Definitions.
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 5, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either negotiating with Fiserv involving a Competing Product or Service, or concerning a potential or existing business or legal dispute with Fiserv, including, but not limited to, litigation, except as may be required by law.
|
(d)
|
You acknowledge and agree that compliance with this Section 5 is necessary to protect the Company, and that a breach of any of this Section 5 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 5, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 5, or to enjoin you from performing services in breach of Section 5(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
(e)
|
You further agree that, in the event of your breach of this Section 5, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
(g)
|
YOU HAVE READ THIS SECTION 5 AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
6.
|
Exercise of Option
.
To exercise the Option, you must complete the transaction through our administrative agent’s website at www.netbenefits.fidelity.com or call its toll free number at (800) 544-9354, specifying the number of Option Shares being purchased as a result of such exercise, and make payment of the full Exercise Price for the Option Shares being purchased. In no event may a fraction of a share be exercised or acquired. You must also pay any taxes or other amounts required to be withheld as provided in Section 9 of this Agreement.
|
7.
|
Termination of Employment
.
|
(a)
|
Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason other than Cause (a “
Termination Event
”), the Option may be exercised to the same extent that you were entitled to exercise the Option on the date of the Termination Event and had not previously done so. The remaining Option Shares that are not vested on such date shall become exercisable as follows:
|
Reason for Termination Event
|
|
Unvested Option Shares that Become Exercisable
|
|
Death, Disability, or Retirement
|
|
100%
|
|
Any other reason
|
|
0%
|
|
(b)
|
Deadline for Exercise
.
|
(i)
|
If your Termination Event is by reason of death, Disability or Retirement, you are (or in the event of your death or Disability resulting in judicial appointment of a guardian ad litem, administrator or other legal representative, the executor or administrator of your estate, any person who shall have acquired the Option through bequest or inheritance or such guardian ad litem, administrator or other legal representative is) entitled to exercise the Option per the terms contained herein within one year after you experience said Termination Event.
|
(ii)
|
Subject to Section 7(d), if your Termination Event is for a reason other than death, Disability or Retirement, you are entitled to exercise the Option per the terms contained herein within 90 days after you experience said Termination Event.
|
(iii)
|
If you die within the exercise periods described in subsections (i) and (ii) above, your executor, the administrator of your estate, or your beneficiary may exercise the Option within one year after your death.
|
(c)
|
Expiration
. Notwithstanding any provision contained in this Section 7 to the contrary, in no event may the Option be exercised to any extent by anyone after the Expiration Date set forth in the Award Memorandum.
|
(d)
|
For Cause Termination Event
. If your employment is terminated for Cause (a “
For Cause Termination Event
”), the Option, whether or not vested, shall terminate immediately. For the sake of clarity, in the event that you experience a For Cause Termination Event, there shall be no accelerated vesting under Section 7(a).
|
(e)
|
Change of Control
. If a Change of Control of the Company occurs, the provisions of Section 17(c) of the Plan shall apply to the Option. If the successor or purchaser in the Change of Control has assumed the Company’s obligations with respect to the Option or provided a substitute award as contemplated by Section 17(c)(i) of the Plan and, within 12 months following the occurrence of the Change of Control, you are terminated without Cause or you terminate your employment for Good Reason (as hereinafter defined), the Option or such substitute award shall become fully vested and exercisable with respect to all Option Shares covered by the Option as of the time immediately prior to such termination of employment and, notwithstanding any other provision hereof, the Option shall become exercisable by you for 90 days following such termination (or such longer period as is otherwise specified in Section 7(b)), and the provisions of Section 5 shall immediately cease to apply.
|
(f)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
(g)
|
No Further Obligation
. The Company will have no further obligations to you under this Agreement if the Option ceases to become exercisable as provided herein.
|
8.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Option Shares to you as soon as practicable after you exercise any part of the Option and pay the Exercise Price Per Option Share and all related withholding taxes. If you die before the Company has distributed any portion of the Option Shares purchased upon exercise, the Company will issue the Option Shares to your estate or in accordance with applicable laws of descent and distribution. The Option Shares will be issued in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to the Option Shares, (b) any applicable federal or state laws, and/or (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) or any stock exchange upon which the Option Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Option Shares to reference any of the foregoing restrictions.
|
9.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Option Shares have been purchased upon exercise of any part of this Option, this Option and the Option Shares issuable upon exercise hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Option, or of any right or privilege conferred hereby, contrary to the provisions of the Plan or of this Agreement, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, this Option and the rights and privileges conferred hereby shall immediately become null and void.
|
10.
|
Conditions to Issuance of Shares
. The Option Shares issued to you hereunder upon exercise and purchase may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Option Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Option Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Option Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the exercise of the Option as the Compensation Committee may establish from time to time for reasons of administrative convenience; and (e) your acceptance of the terms and conditions of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
11.
|
No Rights as Shareholder
.
Until you exercise any part of this Option, purchase Option Shares and the Option Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Option Shares. Specifically, you understand and agree that you do not have voting rights or the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Option or the Option Shares subject hereto.
|
12.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
13.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
14.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement, the exercise of the Option and any disposition of the Option Shares,and that upon the acquisition of any Option Shares, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences of the granting of the Option, the exercise of the Option, the purchase of Option Shares, and the subsequent sale or other disposition of any Option Shares. You understand and agree that when you exercise the Option, and thereby realize gross income (if any) taxable as compensation in respect of such exercise, the Company will be required to withhold federal, state and local taxes on the full amount of the compensation income realized by you and may also be required to withhold other amounts as a result of such exercise unless the Option is an incentive stock option. Accordingly, at or prior to the time that you exercise the Option, you hereby agree to provide the Company with cash funds or Option Shares equal in value to the total federal, state and local taxes and other amounts required to be withheld by the Company or its subsidiary in respect of any compensation income in relation to the Option Shares or make other arrangements satisfactory to the Company regarding such amounts. All matters with respect to the total amount to be withheld as a result of the exercise of the Option shall be determined by the Company in its sole discretion.
|
15.
|
Market Stand-Off
.
The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Option Shares acquired under this Option without the prior written consent of the Company. Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company. In no event, however, shall such period exceed one hundred eighty (180) days.
|
16.
|
General Provisions
.
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
(b)
|
This Agreement, the Award Memorandum and the Plan contain the entire agreement between the Company and you relating to the Option and supersede all prior agreements or understandings relating thereto.
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the administrative agent’s website (
www.netbenefits.fidelity.com
) in the “forms library” and a paper copy is available upon request.
|
(h)
|
During your lifetime, the Option may only be exercised by you or your legal representatives.
|
(i)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
(j)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind the Option and/or the Option Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME] [LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Number of Shares Subject to Option:
|
|
[NUMBER OF SHARES]
|
|
|
|
Exercise Price Per Option Share:
|
|
[EXERCISE PRICE]
|
|
|
|
Type of Option:
|
|
|
|
|
|
Vesting Schedule:
|
|
[VESTING SCHEDULE]
|
|
|
|
Expiration Date:
|
|
10 years after the Grant Date
|
1.
|
Grant Date; Type of Option
.
The Option is granted to you on the Grant Date set forth in the Award Memorandum. If the Option is designated as a “non-qualified stock option” in the Award Memorandum, then the Option will not be treated by you or the Company as an incentive stock option as defined in Section 422 of the Code. If the Option is designated as an “incentive stock option” in the Award Memorandum, then the Option is intended to satisfy the requirements of Section 422 of the Code.
|
2.
|
Termination of Option
. Your right to exercise the Option and to purchase the Option Shares shall expire and terminate in all events on the earliest of (a) the Expiration Date set forth in the Award Memorandum or (b) the date upon which exercise is no longer permitted pursuant to Section 7 of this Agreement or (c) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
3.
|
Exercise Price
. The purchase price to be paid upon the exercise of the Option will be the Exercise Price Per Option Share set forth in the Award Memorandum.
|
4.
|
Vesting; Provisions Relating to Exercise
.
Once you become entitled to exercise any part of the Option (and to purchase Option Shares) pursuant to the vesting schedule set forth in the Award Memorandum, that right will continue until the date on which the Option expires and terminates. The right to purchase Option Shares under the Option is cumulative, so that if the full number of Option Shares is not purchased in a single transaction, the balance may be purchased at any time or from time to time thereafter during the term of the Option. The Administrator, in its sole discretion, may at any time accelerate the time at which the Option becomes exercisable by you with respect to any Option Shares. The Company may cancel, rescind, suspend, withhold or otherwise limit or restrict any unexpired, unpaid or deferred part of the Option at any time if you are not in compliance with all applicable provisions of this Agreement, the Award Memorandum and the Plan.
|
5.
|
Confidential Information, Non-Competition, and Related Covenants
.
|
(a)
|
Definitions.
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 5, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv (or, in the case of Retirement, for a period of 12 months following the later of (x) the date of the last restricted stock unit vesting event following Retirement or (y) the latest date upon which you are entitled to exercise an option following Retirement (in either case, assuming no Post-Retirement Violation)), you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either
|
(d)
|
You acknowledge and agree that compliance with this Section 5 is necessary to protect the Company, and that a breach of any of this Section 5 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 5, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 5, or to enjoin you from performing services in breach of Section 5(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
(e)
|
You further agree that, in the event of your breach of this Section 5, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
(g)
|
YOU HAVE READ THIS SECTION 5 AND SECTION 7(b)(ix) AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
6.
|
Exercise of Option
.
To exercise the Option, you must complete the transaction through our administrative agent’s website at www.netbenefits.fidelity.com or call its toll free number at (800) 544-9354, specifying the number of Option Shares being purchased as a result of such exercise, and make payment of the full Exercise Price for the Option Shares being purchased. In no event may a fraction of a share be exercised or acquired. You must also pay any taxes or other amounts required to be withheld as provided in Section 9 of this Agreement.
|
7.
|
Termination of Employment
.
|
(a)
|
Standard Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason other than Cause (a “
Termination Event
”), the Option may be exercised to the same extent that you were entitled to exercise the Option on the date of the Termination Event and had not previously done so. The remaining Option Shares that are not vested on such date shall become exercisable as follows:
|
Reason for Termination Event
|
Unvested Option Shares that
Become Exercisable
|
Death or Disability
|
100%
|
Retirement
|
Continued Vesting as Described Below
|
Any other reason
|
0%
|
(b)
|
Continued Vesting
.
|
(i)
|
“
Retirement
” means the cessation of service as an employee for any reason other than death, Disability or termination for Cause if:
|
(A)
|
(I) you are at least 50 years of age and your age plus years of service to the Company and its subsidiaries is equal to or greater than 70 (with at least 5 years of continuous service to the Company and its subsidiaries immediately prior to such cessation of service) or (II) you are at least 55 years of age with at least 5 years of continuous service to the Company and its subsidiaries immediately prior to such cessation of service; and
|
(B)
|
you have provided for an orderly transition of your duties to a successor, including by: (I) providing notice to the Company’s Chief Executive Officer (or, if you are the Chief Executive Officer, to the Chairman of the Board of Directors) of your consideration of Retirement sufficiently in advance of your proposed date of Retirement; and (II) assisting with the identification and selection of, and transition of your duties to, a successor ((I) and (II) being referred to herein collectively as the “
Specified Transition Requirements
”).
|
(ii)
|
After your Retirement, the unvested portion of the Option shall continue to vest on the normal vesting dates indicated in the Award Memorandum as if you had not ceased to be an employee.
|
(iii)
|
Notwithstanding the foregoing:
|
(A)
|
If you receive written notification from the Compensation Committee that you failed to provide for an orderly transition of your duties to a successor, then any portion of the Option that is unvested as of the date of such notification shall terminate as of such date.
|
(B)
|
If at any time following your Retirement, one of the following events occurs (a “
Post-Retirement Violation
”), then any portion of the Option that is unvested as of the date of such Post-Retirement Violation shall terminate as of such date: (I) you commence employment of any kind (other than board or public service, work for a not-for-profit or de minimis for-profit employment); (II) you commence work of any kind for a Competitor, including as an employee, board member, consultant or otherwise; or (III) you violate any post-employment covenant applicable to you under any agreement in effect with, or policy of, the Company or any of its subsidiaries, including without limitation those set forth in Section 5.
|
(iv)
|
If, while this Award is outstanding, you commence employment or other work of any kind following your Retirement, you are required to promptly provide written notice to the Company of the name of your employer and the nature of your position or other work.
|
(v)
|
If you receive any benefit under this Award after the date of a Post-Retirement Violation, then you will be obligated to repay to the Company the value of such benefit (with such value to be determined by the Company, which may include a reasonable rate of interest) promptly following your receipt of notice of such repayment obligation from the Company.
|
(vi)
|
All determinations regarding whether you have engaged in a Post-Retirement Violation shall be made by the Compensation Committee.
|
(vii)
|
Notwithstanding the foregoing, if you die after Retirement and prior to the date the Option vests in full (and provided that a Post-Retirement Violation has not occurred), then the Option shall become fully vested as of the date of your death and shall remain exercisable in accordance with subsection (c)(ii) below.
|
(viii)
|
If you are regularly scheduled to work less than 20 hours per calendar week for the Company or any subsidiary of the Company, you will be deemed to have experienced a Termination Event.
|
(ix)
|
Without limiting any other provision of this Agreement, if a Post-Retirement Violation described in (iii)(B)(II) or (III) above occurs following Retirement, the Company shall be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
(c)
|
Deadline for Exercise
.
|
(i)
|
If your Termination Event is by reason of death or Disability, then you are (or in the event of your death or Disability resulting in judicial appointment of a guardian ad litem, administrator or other legal representative, the executor or administrator of your estate, any person who shall have acquired the Option through bequest or inheritance or such guardian ad litem, administrator or other legal representative is) entitled to exercise the Option per the terms contained herein within one year after you experience said Termination Event.
|
(ii)
|
If your Termination Event is by reason of your Retirement, then you are entitled to exercise the Option to the extent vested and per the terms contained herein until the earlier of (A) 5 years following your Termination Event or (B) the Expiration Date set forth in the Award Memorandum; provided that, if you either receive notice under subsection (b)(iii)(A) above that you failed to provide for an orderly transition of your duties to a successor or a Post-Retirement Violation occurs, then, notwithstanding the foregoing, you will be entitled to exercise the Option to the extent vested as of the date of such notice or Post-Retirement Violation, as the case may be, and per the terms contained herein only for the period described in subsection (iii) below (if any time period is remaining) unless the Compensation Committee expressly permits such exercise for a longer period. If the exercise period described in subsection (iii) below has expired as of the date of the Post-Retirement Violation, then this Option shall immediately terminate on such date. Notwithstanding the foregoing, if such Post-Retirement Violation consists solely of the action described in subsection (b)(iii)(B)(I) above, then you will be entitled to exercise the Option to the extent vested as of the date of such Post-Retirement Violation and per the terms contained herein for 90 days following the date of such Post-Retirement Violation, but not beyond the Expiration Date.
|
(iii)
|
Subject to Section 7(e), if your Termination Event is for a reason other than death, Disability or Retirement, you are entitled to exercise the Option per the terms contained herein within 90 days after you experience said Termination Event.
|
(iv)
|
If you die within the exercise periods described in subsections (i), (ii) or (iii) above, your executor, the administrator of your estate, or your beneficiary may exercise the Option within one year after your death.
|
(d)
|
Expiration
. Notwithstanding any provision contained in this Section 7 to the contrary, in no event may the Option be exercised to any extent by anyone after the Expiration Date set forth in the Award Memorandum.
|
(e)
|
For Cause Termination Event
. If your employment is terminated for Cause (a “
For Cause Termination Event
”), the Option, whether or not vested, shall terminate immediately. For the sake of clarity, in the event that you experience a For Cause Termination Event, there shall be no accelerated or continued vesting under Section 7(a) or (b).
|
(f)
|
Change of Control
. If a Change of Control of the Company occurs, the provisions of Section 17(c) of the Plan shall apply to the Option. If the successor or purchaser in the Change of Control has assumed the Company’s obligations with respect to the Option or provided a substitute award as contemplated by Section 17(c)(i) of the Plan and, within 12 months following the occurrence of the Change of Control, you are terminated without Cause or you terminate your employment for Good Reason (as hereinafter defined), the Option or such substitute award shall become fully vested and exercisable with respect to all Option Shares covered by the Option as of the time immediately prior to such termination of employment and, notwithstanding any other provision hereof, the Option shall become exercisable by you for 90 days following such termination (or such longer period as is otherwise specified in Section 7(c)), and the provisions of Section 5 shall immediately cease to apply.
|
(g)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
(h)
|
No Further Obligation
. The Company will have no further obligations to you under this Agreement if the Option ceases to become exercisable as provided herein.
|
8.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Option Shares to you as soon as practicable after you exercise any part of the Option and pay the Exercise Price Per Option Share and all related withholding taxes. If you die before the Company has distributed any portion of the Option Shares purchased upon exercise, the Company will issue the Option Shares to your estate or in accordance with applicable laws of descent and distribution. The Option Shares will be issued in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to the Option Shares, (b) any applicable federal or state laws, and/or (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) or any stock exchange upon which the Option Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Option Shares to reference any of the foregoing restrictions.
|
9.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Option Shares have been purchased upon exercise of any part of this Option, this Option and the Option Shares issuable upon exercise hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Option, or of any right or privilege conferred hereby, contrary to the provisions of the Plan or of this Agreement, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, this Option and the rights and privileges conferred hereby shall immediately become null and void.
|
10.
|
Conditions to Issuance of Shares
. The Option Shares issued to you hereunder upon exercise and purchase may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Option Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Option Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Option Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the exercise of the Option as the Compensation Committee may establish from time to time for reasons of administrative convenience; and (e) your acceptance of the terms and conditions of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
11.
|
No Rights as Shareholder
. Until you exercise any part of this Option, purchase Option Shares and the Option Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Option Shares. Specifically, you understand and agree that you do not have voting rights or the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Option or the Option Shares subject hereto.
|
12.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
13.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
14.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement, the exercise of the Option and any disposition of the Option Shares, and that upon the acquisition of any Option Shares, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences of the granting of the Option, the exercise of the Option, the purchase of Option Shares, and the subsequent sale or other disposition of any Option Shares. You understand and agree that when you exercise the Option, and thereby realize gross income
|
15.
|
Market Stand-Off
. The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Option Shares acquired under this Option without the prior written consent of the Company. Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company. In no event, however, shall such period exceed one hundred eighty (180) days.
|
16.
|
General Provisions
.
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
(b)
|
This Agreement, the Award Memorandum and the Plan contain the entire agreement between the Company and you relating to the Option and supersede all prior agreements or understandings relating thereto.
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the administrative agent’s website (www.netbenefits.fidelity.com) in the “forms library” and a paper copy is available upon request.
|
(h)
|
During your lifetime, the Option may only be exercised by you or your legal representatives.
|
(i)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
(j)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind the Option and/or the Option Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME] [LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Number of Shares Subject to Option:
|
|
[NUMBER OF SHARES]
|
|
|
|
Exercise Price Per Option Share:
|
|
[EXERCISE PRICE]
|
|
|
|
Type of Option:
|
|
|
|
|
|
Vesting Schedule:
|
|
[VESTING SCHEDULE]
|
|
|
|
Expiration Date:
|
|
10 years after the Grant Date
|
1.
|
Grant Date; Type of Option
.
The Option is granted to you on the Grant Date set forth in the Award Memorandum. If the Option is designated as a “non-qualified stock option” in the Award Memorandum, then the Option will not be treated by you or the Company as an incentive stock option as defined in Section 422 of the Code. If the Option is designated as an “incentive stock option” in the Award Memorandum, then the Option is intended to satisfy the requirements of Section 422 of the Code.
|
2.
|
Termination of Option
. Your right to exercise the Option and to purchase the Option Shares shall expire and terminate in all events on the earliest of (a) the Expiration Date set forth in the Award Memorandum or (b) the date upon which exercise is no longer permitted pursuant to Section 7 of this Agreement or (c) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
3.
|
Exercise Price
. The purchase price to be paid upon the exercise of the Option will be the Exercise Price Per Option Share set forth in the Award Memorandum.
|
4.
|
Vesting; Provisions Relating to Exercise
.
Once you become entitled to exercise any part of the Option (and to purchase Option Shares) pursuant to the vesting schedule set forth in the Award Memorandum, that right will continue until the date on which the Option expires and terminates. The right to purchase Option Shares under the Option is cumulative, so that if the full number of Option Shares is not purchased in a single transaction, the balance may be purchased at any time or from time to time thereafter during the term of the Option. The Administrator, in its sole discretion, may at any time accelerate the time at which the Option becomes exercisable by you with respect to any Option Shares. The Company may cancel, rescind, suspend, withhold or otherwise limit or restrict any unexpired, unpaid or deferred part of the Option at any time if you are not in compliance with all applicable provisions of this Agreement, the Award Memorandum and the Plan.
|
5.
|
Confidential Information, Non-Competition, and Related Covenants
.
|
(a)
|
Definitions.
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 5, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You agree to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding
|
(d)
|
You acknowledge and agree that compliance with this Section 5 is necessary to protect the Company, and that a breach of any of this Section 5 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 5, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 5, or to enjoin you from performing services in breach of Section 5(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
(e)
|
You further agree that, in the event of your breach of this Section 5, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
(g)
|
YOU HAVE READ THIS SECTION 5 AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
6.
|
Exercise of Option
.
To exercise the Option, you must complete the transaction through our administrative agent’s website at www.netbenefits.fidelity.com or call its toll free number at (800) 544-9354, specifying the number of Option Shares being purchased as a result of such exercise, and make payment of the full Exercise Price for the Option Shares being purchased. In no event may a fraction of a share be exercised or acquired. You must also pay any taxes or other amounts required to be withheld as provided in Section 9 of this Agreement.
|
7.
|
Termination of Employment
.
|
(a)
|
Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason other than Cause (a “
Termination Event
”), the Option may be exercised to the same extent that you were entitled to exercise the Option on the date of the Termination Event and had not previously done so. The remaining Option Shares that are not vested on such date shall become exercisable as follows:
|
|
Unvested Option Shares that
|
Reason for Termination Event
|
Become Exercisable
|
Death or Disability
|
100%
|
Any other reason
|
0%
|
(b)
|
Deadline for Exercise
.
|
(i)
|
If your Termination Event is by reason of death or Disability, then you are (or in the event of your death or Disability resulting in judicial appointment of a guardian ad litem, administrator or other legal representative, the executor or administrator of your estate, any person who shall have acquired the Option through bequest or inheritance or such guardian ad litem, administrator or other legal representative is) entitled to exercise the Option per the terms contained herein within one year after you experience said Termination Event.
|
(ii)
|
Subject to Section 7(d), if your Termination Event is for a reason other than death or Disability, you are entitled to exercise the Option per the terms contained herein within 90 days after you experience said Termination Event.
|
(iii)
|
If you die within the exercise periods described in subsections (i) or (ii) above, your executor, the administrator of your estate, or your beneficiary may exercise the Option within one year after your death.
|
(c)
|
Expiration
. Notwithstanding any provision contained in this Section 7 to the contrary, in no event may the Option be exercised to any extent by anyone after the Expiration Date set forth in the Award Memorandum.
|
(d)
|
For Cause Termination Event
. If your employment is terminated for Cause (a “
For Cause Termination Event
”), the Option, whether or not vested, shall terminate immediately. For the sake of clarity, in the event that you experience a For Cause Termination Event, there shall be no accelerated vesting under Section 7(a).
|
(e)
|
Change of Control
. If a Change of Control of the Company occurs, the provisions of Section 17(c) of the Plan shall apply to the Option. If the successor or purchaser in the Change of Control has assumed the Company’s obligations with respect to the Option or provided a substitute award as contemplated by Section 17(c)(i) of the Plan and, within 12 months following the occurrence of the Change of Control, you are terminated without Cause or you terminate your employment for Good Reason (as hereinafter defined), the Option or such substitute award shall become fully vested and exercisable with respect to all Option Shares covered by the Option as of the time immediately prior to such termination of employment and, notwithstanding any other provision hereof, the Option shall become exercisable by you for 90 days following such termination (or such longer period as is otherwise specified in Section 7(b)), and the provisions of Section 5 shall immediately cease to apply.
|
(f)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
(g)
|
No Further Obligation
. The Company will have no further obligations to you under this Agreement if the Option ceases to become exercisable as provided herein.
|
8.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Option Shares to you as soon as practicable after you exercise any part of the Option and pay the Exercise Price Per Option Share and all related withholding taxes. If you die before the Company has distributed any portion of the Option Shares purchased upon exercise, the Company will issue the Option Shares to your estate or in accordance with applicable laws of descent and distribution. The Option Shares will be issued in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to the Option Shares, (b) any applicable federal or state laws, and/or (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) or any stock exchange upon which the Option Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Option Shares to reference any of the foregoing restrictions.
|
9.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Option Shares have been purchased upon exercise of any part of this Option, this Option and the Option Shares issuable upon exercise hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Option, or of any right or privilege conferred hereby, contrary to the provisions of the Plan or of this Agreement, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, this Option and the rights and privileges conferred hereby shall immediately become null and void.
|
10.
|
Conditions to Issuance of Shares
. The Option Shares issued to you hereunder upon exercise and purchase may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Option Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Option Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Option Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the exercise of the Option as the Compensation Committee may establish from time to time for reasons of administrative convenience; and (e) your acceptance of the terms and conditions of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
11.
|
No Rights as Shareholder
. Until you exercise any part of this Option, purchase Option Shares and the Option Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Option Shares. Specifically, you understand and agree that you do not have voting rights or the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Option or the Option Shares subject hereto.
|
12.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
13.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
14.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement, the exercise of the Option and any disposition of the Option Shares, and that upon the acquisition of any Option Shares, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences of the granting of the Option, the exercise of the Option, the purchase of Option Shares, and the subsequent sale or other disposition of any Option Shares. You understand and agree that when you exercise the Option, and thereby realize gross income (if any) taxable as compensation in respect of such exercise, the Company will be required to withhold federal, state and local taxes on the full amount of the compensation income realized by you and may also be required to withhold other amounts as a result of such exercise unless the Option is an incentive stock option. Accordingly, at or prior to the time that you exercise the Option, you hereby agree to provide the Company with cash funds or Option Shares equal in value to the total federal, state and local taxes and other amounts required to be withheld by the Company or its subsidiary in respect of any compensation income in relation to the Option Shares or make other arrangements satisfactory to the Company regarding such amounts. All matters with respect to the total amount to be withheld as a result of the exercise of the Option shall be determined by the Company in its sole discretion.
|
15.
|
Market Stand-Off
. The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Option Shares acquired under this Option without the prior written consent of the Company. Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company. In no event, however, shall such period exceed one hundred eighty (180) days.
|
16.
|
General Provisions
.
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
(b)
|
This Agreement, the Award Memorandum and the Plan contain the entire agreement between the Company and you relating to the Option and supersede all prior agreements or understandings relating thereto.
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the administrative agent’s website (www.netbenefits.fidelity.com) in the “forms library” and a paper copy is available upon request.
|
(h)
|
During your lifetime, the Option may only be exercised by you or your legal representatives.
|
(i)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
(j)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind the Option and/or the Option Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME]
[LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Target Units:
|
|
[NUMBER OF SHARES AT TARGET]
|
|
|
|
Performance Period:
|
|
[PERIOD]
|
|
|
|
Performance Formula:
|
|
[PERFORMANCE FORMULA]
|
|
|
|
Performance Goal(s):
|
|
[PERFORMANCE GOALS]
|
1.
|
Grant Date
.
The Award is granted to you on the Grant Date set forth in the Award Memorandum.
|
2.
|
Vesting
.
This Award will vest (if at all) as specified in the Award Memorandum on the date the Compensation Committee certifies the level of achievement of the Performance Goal(s), provided you remain in employment through the last day of the Performance Period. Subject to any deferral election then in effect, the Shares subject to this Award will be issued as indicated in this Agreement. This Award also may continue to vest following your Retirement (as defined below), death or Disability as described in Section 5(a).
|
3.
|
Termination of Award
. Your Award (except for the provisions of Section 4) shall terminate in all events on the earliest of (a) the date upon which vesting is no longer permitted pursuant to Section 5 of this Agreement, (b) the date the Shares due hereunder have been issued to you, or (c) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
4.
|
Confidential Information; Non-Competition; Related Covenants
.
|
|
(a)
|
Definitions.
|
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is disclosed by you under order of law or governmental regulation; provided, however, that you agree to notify the General Counsel of Fiserv upon receipt of any request for disclosure as soon as possible prior to any such disclosure so that appropriate safeguards may be maintained.
|
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 4, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
|
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You agree to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.
|
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or, where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
|
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
|
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
|
You understand that if you are found to have wrongfully misappropriated a trade secret, you may be liable to the Company for, among other things, exemplary damages and attorneys’ fees.
|
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv (the “
Restrictive Period
”), you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either negotiating with Fiserv involving a Competing Product or Service, or concerning a potential or existing business or legal dispute with Fiserv, including, but not limited to, litigation, except as may be required by law.
|
|
(d)
|
You acknowledge and agree that compliance with this Section 4 is necessary to protect the Company, and that a breach of any of this Section 4 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 4, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 4, or to enjoin you from performing services in breach of Section 4(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
|
(e)
|
You further agree that, in the event of your breach of this Section 4, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
|
(g)
|
YOU HAVE READ THIS SECTION 4 AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
5.
|
Termination of Employment
.
|
|
(a)
|
Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason (a “
Termination Event
”) prior to the last day of the Performance Period, then the Award shall terminate on the date on which such Termination Event occurs;
provided that
, if the reason for your Termination Event is:
(i) Disability, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment, but multiplied times a fraction, the numerator of which is the number of completed whole calendar months of your employment during the Performance Period and the denominator of which is [the total number of calendar months in the Performance Period];
(ii) Death, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment, but multiplied times a fraction, the numerator of which is the number of completed whole calendar months of your employment during the Performance Period and the denominator of which is [the total number of calendar months in the Performance Period], and such Shares shall be issued at that time to your designated beneficiary or, if none, to your estate; or
(iii) Retirement, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment, but multiplied times a fraction, the numerator of which is the number of completed whole calendar months of your employment during the Performance Period and the denominator of which is [the total number of calendar months in the Performance Period]. If you die after Retirement, then your designated beneficiary, or if none, your estate, shall become entitled to receive the number of Shares you would have received, if any, pursuant to this paragraph.
|
|
|
If you breach Section 4 of this Agreement, you will forfeit this Award and no Shares will be issuable under this Award. In addition, if you engage in conduct after the end of the Restrictive Period in Section 4 but prior to the payment of Shares following the end of the Performance Period which, if engaged in during the Restrictive Period would have constituted a breach of Section 4, then you will forfeit this Award and no Shares will be issuable under this Award.
For purposes of this Section 5, “
Retirement
” means the cessation of service as an employee after the first anniversary of the first day of the Performance Period for any reason other than death, Disability or termination for Cause if (A) you are at least 60 years of age and your age plus years of service to the Company and its subsidiaries is equal to or greater than 70 or (B) you are at least 65 years of age.
If you are regularly scheduled to work less than 20 hours per calendar week for the Company or any subsidiary of the Company, you will be deemed to have experienced a Termination Event.
|
|
|
|
|
(b)
|
Change of Control
. If a Change of Control of the Company occurs prior to the end of the Performance Period, then as of the date of the Change of Control, you will be paid cash in an amount equal to the fair market value (as of the date of the Change of Control) of such number of Shares as is determined by multiplying the number of Target Units set forth in the Award Memorandum times [
]%. Thereafter, the Award shall terminate.
|
|
(c)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
|
(d)
|
Termination for Cause
. Notwithstanding anything herein to the contrary, if you are terminated from employment by the Company for Cause, then this Award will forfeit immediately as of the date of such termination.
|
|
(e)
|
No Further Obligation
. The Company will have no further obligations to you under this Award if the Award terminates as provided herein.
|
6.
|
Deferral of Performance Share Units
. If you are eligible to, and properly elect to, defer delivery of all or part of the Shares otherwise issuable under this Award, such deferral will be governed by the Performance Share Unit Deferral Election Form executed by you separately from this Agreement.
|
7.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Shares to you as soon as practicable after the Award vests (pursuant to the terms hereof) with respect to such Shares, or, if a deferral election was made, at the time specified in the Deferral Election Form. If you die before the Company has distributed the Shares due with respect to the vested Performance Share Units, the Company will issue the Shares to your estate or in accordance with applicable laws of descent and distribution. The Shares will be issued and delivered in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to this Award or the Shares, (b) any applicable federal or state laws, and/or (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) of any stock exchange upon which the Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Shares to reference any of the foregoing restrictions.
|
8.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Shares have been issued under this Award, this Award and the Shares issuable hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Award, or of any
|
9.
|
Conditions to Issuance of Shares
. The Shares issued to you hereunder may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the date of vesting of the Award or the payment event specified in a deferral election as the Compensation Committee may establish from time to time for reasons of administrative convenience (provided that any such period shall be in compliance with Code Section 409A); and (e) your acceptance of the terms and conditions of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
10.
|
Dividends; No Rights as Shareholder
.
If the Company declares a cash dividend and the dividend record date occurs prior to the date the Award vests, you will be credited with an additional number of Target Units on the date the cash dividends are paid to the Company shareholders equal to (a) the amount of cash dividends payable with respect to a number of shares of stock equal to your Target Units divided by (b) the Fair Market Value of a Share on the date the dividend is paid. Until this Award vests and the Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Shares. Specifically, you understand and agree that you do not have voting rights or, except as provided in this Section 10, the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Award or the Shares subject hereto.
|
11.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
13.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement and any disposition of Shares and that upon the acquisition of any Shares subject to this Award, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences associated with the granting of the Award, the vesting of the Award, the deferral of all or a portion of the Shares otherwise issuable upon vesting of the Award,
|
14.
|
Market Stand-Off
. The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Award without the prior written consent of the Company. Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company. In no event, however, shall such period exceed one hundred eighty (180) days.
|
15.
|
General Provisions
.
|
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
|
(b)
|
This Agreement, the Award Memorandum, the Plan and the Restricted Stock Unit Deferral Election Form, if any, contain the entire agreement between the Company and you relating to the Award and the Shares and supersede all prior agreements or understandings relating thereto.
|
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the Company’s administrative agent’s website in the “forms library” (www.netbenefits.fidelity.com) in the “forms library” and a paper copy is available upon request.
|
|
(h)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
|
(i)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind this Award and/or the Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME]
[LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Target Units:
|
|
[NUMBER OF SHARES AT TARGET]
|
|
|
|
Performance Period:
|
|
[PERIOD]
|
|
|
|
Performance Formula:
|
|
[PERFORMANCE FORMULA]
|
|
|
|
Performance Goal(s):
|
|
[PERFORMANCE GOALS]
|
1.
|
Grant Date
.
The Award is granted to you on the Grant Date set forth in the Award Memorandum.
|
2.
|
Vesting
.
This Award will vest (if at all) as specified in the Award Memorandum on the date the Compensation Committee certifies the level of achievement of the Performance Goal(s), provided you remain in employment through the last day of the Performance Period. Subject to any deferral election then in effect, the Shares subject to this Award will be issued as indicated in this Agreement. This Award also may continue to vest following your Retirement (as defined below), death or Disability as described in Section 5(a).
|
3.
|
Termination of Award
. Your Award (except for the provisions of Section 4) shall terminate in all events on the earliest of (a) the date upon which vesting is no longer permitted pursuant to Section 5 of this Agreement, (b) the date the Shares due hereunder have been issued to you, or (c) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
4.
|
Confidential Information; Non-Competition; Related Covenants
.
|
|
(a)
|
Definitions.
|
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is disclosed by you under order of law or governmental regulation; provided, however, that you agree to notify the General Counsel of Fiserv upon receipt of any request for disclosure as soon as possible prior to any such disclosure so that appropriate safeguards may be maintained.
|
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 4, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
|
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You agree to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.
|
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or, where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
|
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
|
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
|
You understand that if you are found to have wrongfully misappropriated a trade secret, you may be liable to the Company for, among other things, exemplary damages and attorneys’ fees.
|
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv (or, in the case of Retirement, from the date of your termination until 12 months after the latest of (x) the date of the last restricted stock unit vesting event following Retirement or (y) the latest date upon which you are entitled to exercise any stock option following Retirement or (z) the end date of the last Performance Period ending after Retirement under performance share unit awards), you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either negotiating with Fiserv involving a Competing Product or Service, or concerning a potential or existing business or legal dispute with Fiserv, including, but not limited to, litigation, except as may be required by law.
|
|
(d)
|
You acknowledge and agree that compliance with this Section 4 is necessary to protect the Company, and that a breach of any of this Section 4 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 4, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 4, or to enjoin you from performing services in breach of Section 4(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
|
(e)
|
You further agree that, in the event of your breach of this Section 4, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
|
(g)
|
YOU HAVE READ THIS SECTION 4 AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
5.
|
Termination of Employment
.
|
|
(a)
|
Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason (a “
Termination Event
”) prior to the last day of the Performance Period, then the Award shall terminate on the date on which such Termination Event occurs;
provided that
, if the reason for your Termination Event is:
(i) Disability, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment, but multiplied times a fraction, the numerator of which is the number of completed whole calendar months of your employment during the Performance Period and the denominator of which is [the total number of calendar months in the Performance Period];
(ii) Death, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment, but multiplied times a fraction, the numerator of which is the number of completed whole calendar months of your employment during the Performance Period and the denominator of which is [the total number of calendar months in the Performance Period], and such Shares shall be issued at that time to your designated beneficiary or, if none, to your estate; or
|
|
|
(iii) Retirement, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment. Notwithstanding the foregoing:
(A) If you receive written notification from the Compensation Committee that you failed to provide for an orderly transition of your duties to a successor, then any portion of the Award that is unvested as of the date of such notification shall terminate as of such date.
(B) If, at any time following your Retirement, one of the following events occurs (a “
Post-Retirement Violation
”), then any portion of the Award that is unvested as of the date of such Post-Retirement Violation shall terminate as of the date such event occurs: (I) you commence employment of any kind (other than board or public service, work for a not-for-profit or de minimis for-profit employment); (II) you commence work of any kind for a Competitor, including as an employee, board member, consultant or otherwise; or (III) you violate any post-employment covenant applicable to you under any agreement in effect with, or policy of, the Company or any of its subsidiaries, including without limitation those set forth in Section 4.
(C) If, while this Award is outstanding, you commence employment or other work of any kind following your Retirement, you are required to promptly provide written notice to the Company of the name of your employer and the nature of your proposed position or other work.
(D) If you receive any benefit under this Award after the date of a Post-Retirement Violation, then you will be obligated to repay to the Company the value of such benefit (with such value to be determined by the Company, which may include a reasonable rate of interest) promptly following your receipt of notice of such repayment obligation from the Company.
(E) All determinations regarding whether you have engaged in a Post-Retirement Violation shall be made by the Compensation Committee.
(F) Without limiting any other provision of this Agreement, if a Post-Retirement Violation described in (iii)(B)(II) or (III) above occurs following Retirement, the Company shall be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
If you die after Retirement and prior to the date that this Award vests (and provided that a Post-Retirement Violation has not occurred), then your designated beneficiary, or if none, your estate, shall become entitled to receive the number of Shares you would have received, if any, pursuant to this paragraph (iii).
If you are regularly scheduled to work less than 20 hours per calendar week for the Company or any subsidiary of the Company, you will be deemed to have experienced a Termination Event.
|
|
(b)
|
Retirement
.
For purposes of this Section 5, “
Retirement
” means the cessation of service as an employee after the first anniversary of the first day of the Performance Period, for any reason other than death, Disability or termination for Cause, if:
(i) (A) you are at least 50 years of age and your age plus years of service to the Company and its subsidiaries is equal to or greater than 70 (with at least 5 years of continuous service to the Company and its subsidiaries immediately prior to such cessation of service) or (B) you are at least 55 years of age with at least 5 years of continuous service to the Company and its subsidiaries immediately prior to such cessation of service; and
|
|
|
(ii) you have provided for an orderly transition of your duties to a successor, including by: (A) providing notice to the Company’s Chief Executive Officer (or, if you are the Chief Executive Officer, to the Chairman of the Board of Directors) of your consideration of Retirement sufficiently in advance of your proposed date of Retirement; and (B) assisting with the identification and selection of, and transition of your duties to, a successor ((A) and (B) being referred to herein collectively as the “
Specified Transition Requirements
”).
If you meet the criteria in paragraph (i) above and you satisfy the Specified Transition Requirements, your cessation of service will be deemed to be a qualifying Retirement; provided that, the Compensation Committee may determine, within 30 days after your cessation of service, that you failed to provide for an orderly transition of your duties to a successor. By way of example only, this could result from providing too short of notice or not providing an adequate amount of transition assistance.
|
|
(c)
|
Change of Control
. If a Change of Control of the Company occurs prior to the end of the Performance Period, then as of the date of the Change of Control, you will be paid cash in an amount equal to the fair market value (as of the date of the Change of Control) of such number of Shares as is determined by multiplying the number of Target Units set forth in the Award Memorandum times [
]%. Thereafter, the Award shall terminate.
|
|
(d)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
|
(e)
|
Termination for Cause
. Notwithstanding anything herein to the contrary, if you are terminated from employment by the Company for Cause, then this Award will forfeit immediately as of the date of such termination.
|
|
(f)
|
No Further Obligation
. The Company will have no further obligations to you under this Award if the Award terminates as provided herein.
|
6.
|
Deferral of Performance Share Units
. If you are eligible to, and properly elect to, defer delivery of all or part of the Shares otherwise issuable under this Award, such deferral will be governed by the Performance Share Unit Deferral Election Form executed by you separately from this Agreement.
|
7.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Shares to you as soon as practicable after the Award vests (pursuant to the terms hereof) with respect to such Shares, or, if a deferral election was made, at the time specified in the Deferral Election Form. If you die before the Company has distributed the Shares due with respect to the vested Performance Share Units, the Company will issue the Shares to your estate or in accordance with applicable laws of descent and distribution. The Shares will be issued and delivered in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to this Award or the Shares, (b) any applicable federal or state laws, and/or (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) of any stock exchange upon which the Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Shares to reference any of the foregoing restrictions.
|
8.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Shares have been issued under this Award, this Award and the Shares issuable hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Award, or of any right or privilege conferred hereby, contrary to the provisions of the Plan or of this Agreement, or upon
|
9.
|
Conditions to Issuance of Shares
. The Shares issued to you hereunder may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the date of vesting of the Award or the payment event specified in a deferral election as the Compensation Committee may establish from time to time for reasons of administrative convenience (provided that any such period shall be in compliance with Code Section 409A); and (e) your acceptance of the terms and conditions of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
10.
|
Dividends; No Rights as Shareholder
.
If the Company declares a cash dividend and the dividend record date occurs prior to the date the Award vests, you will be credited with an additional number of Target Units on the date the cash dividends are paid to the Company shareholders equal to (a) the amount of cash dividends payable with respect to a number of shares of stock equal to your Target Units divided by (b) the Fair Market Value of a Share on the date the dividend is paid. Until this Award vests and the Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Shares. Specifically, you understand and agree that you do not have voting rights or, except as provided in this Section 10, the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Award or the Shares subject hereto.
|
11.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
12.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
13.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement and any disposition of Shares and that upon the acquisition of any Shares subject to this Award, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences associated with the granting of the Award, the vesting of the Award, the deferral of all or a portion of the Shares otherwise issuable upon vesting of the Award, and the subsequent sale or other disposition of any Shares. You understand and agree that when
|
14.
|
Market Stand-Off
. The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Award without the prior written consent of the Company. Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company. In no event, however, shall such period exceed one hundred eighty (180) days.
|
15.
|
General Provisions
.
|
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
|
(b)
|
This Agreement, the Award Memorandum, the Plan and the Restricted Stock Unit Deferral Election Form, if any, contain the entire agreement between the Company and you relating to the Award and the Shares and supersede all prior agreements or understandings relating thereto.
|
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the Company’s administrative agent’s website in the “forms library” (www.netbenefits.fidelity.com) in the “forms library” and a paper copy is available upon request.
|
|
(h)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
|
(i)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind this Award and/or the Shares in certain circumstances.
|
|
|
|
Employee:
|
|
[FIRST NAME] [LAST NAME]
|
|
|
|
Grant Date:
|
|
[GRANT DATE]
|
|
|
|
Target Units:
|
|
[NUMBER OF SHARES AT TARGET]
|
|
|
|
Performance Period:
|
|
[PERIOD]
|
|
|
|
Performance Formula:
|
|
[PERFORMANCE FORMULA]
|
|
|
|
Performance Goal(s):
|
|
[PERFORMANCE GOALS]
|
1.
|
Grant Date
.
The Award is granted to you on the Grant Date set forth in the Award Memorandum.
|
2.
|
Vesting
.
This Award will vest (if at all) as specified in the Award Memorandum on the date the Compensation Committee certifies the level of achievement of the Performance Goal(s), provided you remain in employment through the last day of the Performance Period. Subject to any deferral election then in effect, the Shares subject to this Award will be issued as indicated in this Agreement. This Award also may continue to vest following your death or Disability as described in Section 5(a).
|
3.
|
Termination of Award
. Your Award (except for the provisions of Section 4) shall terminate in all events on the earliest of (a) the date upon which vesting is no longer permitted pursuant to Section 5 of this Agreement, (b) the date the Shares due hereunder have been issued to you, or (c) your failure to accept the terms of this Agreement, the Award Memorandum and the Plan within the time period and in the manner specified in this Agreement.
|
4.
|
Confidential Information; Non-Competition; Related Covenants
.
|
|
(a)
|
Definitions.
|
|
(i)
|
“
Fiserv
” means the Company, its direct and indirect subsidiaries, affiliated entities, successors, and assigns.
|
|
(ii)
|
“
Confidential Information
” means all trade secrets, Innovations (as defined below), confidential or proprietary business information and data, computer software, and database technologies or technological information, formulae, templates, algorithms, designs, process and systems information, processes, intellectual property rights, marketing plans, client lists and specifications, pricing and cost information and any other confidential information of Fiserv or its clients, vendors or subcontractors that relates to the business of Fiserv or to the business of any client, vendor or subcontractor of Fiserv or any other party with whom Fiserv agrees to hold information in confidence, whether patentable, copyrightable or protectable as a trade secret or not, except: (A) information that is, at the time of disclosure, in the public domain or that is subsequently published or otherwise becomes part of the public domain through no fault of yours; or (B) information that is disclosed by you under order of law or governmental regulation; provided, however, that you agree to notify the General Counsel of Fiserv upon receipt of any request for disclosure as soon as possible prior to any such disclosure so that appropriate safeguards may be maintained.
|
|
(iii)
|
“
Competing Product or Service
” means any product or service that is sold in competition with, or is being developed and that will compete with, a product or service developed, manufactured, or sold by Fiserv. For purposes of this Section 4, Competing Products or Services as to you are limited to products and/or services with respect to which you participated in the development, planning, testing, sale, marketing or evaluation on behalf of Fiserv during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, or for which you supervised one or more Fiserv employees, units, divisions or departments in doing so.
|
|
|
(iv)
|
“
Competitor
” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in the sale or marketing of any Competing Product or Service.
|
|
(v)
|
“
Innovations
” means all developments, improvements, designs, original works of authorship, formulas, processes, software programs, databases, and trade secrets, whether or not patentable, copyrightable or protectable as trade secrets, that you, either by yourself or jointly with others, create, modify, develop, or implement during the period of your employment with Fiserv that relate in any way to Fiserv’s business.
|
|
(vi)
|
“
Moral Rights
” means any rights to claim authorship of a work of authorship, to object to or prevent the modification of any such work of authorship, or to withdraw from circulation or control the publication or distribution of any such work of authorship.
|
|
(vii)
|
“
Client
” means any person, association or entity: (A) for which you directly performed services or for which you supervised others in performing services with Fiserv, during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(viii)
|
“
Prospective Client
” means any client: (A) with which Fiserv was in active business discussions or negotiations at any time during any part of your employment with Fiserv, or after the termination of your employment, during any part of the 24 months preceding the termination of your employment with Fiserv, in which you participated or for which you directly performed services or for which you supervised others in performing services with Fiserv; or (B) about which you have Confidential Information as a result of your employment with Fiserv.
|
|
(b)
|
During your employment, Fiserv will provide you with Confidential Information relating to Fiserv, its business and clients, the disclosure or misuse of which would cause severe and irreparable harm to Fiserv. You agree that all Confidential Information is and shall remain the sole and absolute property of Fiserv. Upon the termination of your employment for any reason, you shall immediately return to Fiserv all documents and materials that contain or constitute Confidential Information, in any form whatsoever, including but not limited to, all copies, abstracts, electronic versions, and summaries thereof. You further agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company:
|
|
(i)
|
You will not disclose, use, copy or duplicate, or otherwise permit the use, disclosure, copying or duplication of any Confidential Information of Fiserv, other than in connection with the authorized activities conducted in the course of your employment with Fiserv. You agree to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, copying or duplication of Confidential Information.
|
|
(ii)
|
All Innovations are and shall remain the sole and absolute property of Fiserv. You will provide all assistance requested by Fiserv, at its expense, in the preservation of its interest in any Innovations in any country, and hereby assign and agree to assign to Fiserv all rights, title and interest in and to all worldwide patents, patent applications, copyrights, trade secrets and other intellectual property rights in any Innovation. You also assign and agree to assign to Fiserv, or, where applicable, to waive, which waiver shall inure to the benefit of Fiserv and its assigns, all Moral Rights in any Innovation.
|
|
(iii)
|
Notwithstanding the preceding statements, you understand that, pursuant to 18 U.S.C. §1833(b)(1) and §1833(b)(2):
|
|
|
(A)
|
An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (I) is made (x) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney and (y) solely for the purpose of reporting or investigating a suspected violation of law; or (II) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
|
|
|
(B)
|
An individual who files a lawsuit for retaliation by the Company for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (I) files any document containing the trade secret under seal and (II) does not disclose the trade secret, except pursuant to court order.
|
|
You understand that if you are found to have wrongfully misappropriated a trade secret, you may be liable to the Company for, among other things, exemplary damages and attorneys’ fees.
|
|
(c)
|
You agree that, without the written consent of the Chief Executive Officer of the Company or, in the case of the Chief Executive Officer of the Company, without the written approval of the Board of Directors of the Company, you shall not engage in any of the conduct described in subsections (i) or (ii), below, either directly or indirectly, or as an employee, contractor, consultant, partner, officer, director or stockholder, other than a stockholder of less than 5% of the equities of a publicly traded corporation, or in any other capacity for any person, firm, partnership or corporation:
|
|
(i)
|
During the time of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv (except to the extent required by your employment with Fiserv); or (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv.
|
|
(ii)
|
For a period of 12 months following the termination of your employment with Fiserv, you will not: (A) perform duties as or for a Competitor, Client or Prospective Client of Fiserv that are the same as or similar to the duties performed by you for Fiserv at any time during any part of the 24 month period preceding the termination of your employment with Fiserv; (B) participate in the inducement of or otherwise encourage Fiserv employees, clients, or vendors to currently and/or prospectively breach, modify, or terminate any agreement or relationship they have or had with Fiserv during any part of the 24 month period preceding the termination of your employment with Fiserv; or (C) participate voluntarily or provide assistance or information to any person or entity either negotiating with Fiserv involving a Competing Product or Service, or concerning a potential or existing business or legal dispute with Fiserv, including, but not limited to, litigation, except as may be required by law.
|
|
(d)
|
You acknowledge and agree that compliance with this Section 4 is necessary to protect the Company, and that a breach of any of this Section 4 will result in irreparable and continuing damage to the Company for which there will be no adequate remedy at law. In the event of a breach of this Section 4, or any part thereof, the Company, and its successors and assigns, shall be entitled to injunctive relief and to such other and further relief as is proper under the circumstances. The Company shall institute and prosecute proceedings in any Court of competent jurisdiction either in law or in equity to obtain damages for any such breach of this Section 4, or to enjoin you from performing services in breach of Section 4(c) during the term of employment and for a period of 12 months following the termination of employment. You hereby agree to submit to the jurisdiction of any Court of competent jurisdiction in any disputes that arise under this Agreement.
|
|
(e)
|
You further agree that, in the event of your breach of this Section 4, the Company shall also be entitled to recover the value of any amounts previously paid or payable or any shares (or the value of any shares) delivered or deliverable to you pursuant to any Fiserv bonus program, this Agreement, and any other Fiserv plan or arrangement.
|
|
(f)
|
You agree that the terms of this Agreement shall survive the termination of your employment with the Company.
|
|
(g)
|
YOU HAVE READ THIS SECTION 4 AND AGREE THAT THE CONSIDERATION PROVIDED BY THE COMPANY IS FAIR AND REASONABLE AND FURTHER AGREE THAT GIVEN THE IMPORTANCE TO THE COMPANY OF ITS CONFIDENTIAL AND PROPRIETARY INFORMATION, THE POST-EMPLOYMENT RESTRICTIONS ON YOUR ACTIVITIES ARE LIKEWISE FAIR AND REASONABLE.
|
5.
|
Termination of Employment
.
|
|
(a)
|
Vesting
. If you cease to be an employee of the Company or any subsidiary of the Company for any reason (a “
Termination Event
”) prior to the last day of the Performance Period, then the Award shall terminate on the date on which such Termination Event occurs;
provided that
, if the reason for your Termination Event is:
(i) Disability, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment, but multiplied times a fraction, the numerator of which is the number of completed whole calendar months of your employment during the Performance Period and the denominator of which is [the total number of calendar months in the Performance Period]; or
(ii) Death, then the number of Shares issuable under this Award, if any, shall be determined after the end of the Performance Period as if you had not terminated employment, but multiplied times a fraction, the numerator of which is the number of completed whole calendar months of your employment during the Performance Period and the denominator of which is [the total number of calendar months in the Performance Period], and such Shares shall be issued at that time to your designated beneficiary or, if none, to your estate.
If you are regularly scheduled to work less than 20 hours per calendar week for the Company or any subsidiary of the Company, you will be deemed to have experienced a Termination Event.
|
|
|
|
|
(b)
|
Change of Control
. If a Change of Control of the Company occurs prior to the end of the Performance Period, then as of the date of the Change of Control, you will be paid cash in an amount equal to the fair market value (as of the date of the Change of Control) of such number of Shares as is determined by multiplying the number of Target Units set forth in the Award Memorandum times [
]%. Thereafter, the Award shall terminate.
|
|
(c)
|
Service as Director
. For purposes of this Agreement, an employee of the Company, if also serving as a director, will not be deemed to have terminated employment for purposes of this Agreement until his or her service as a director ends, and his or her years of service will be deemed to include years of service as a director.
|
|
(d)
|
Termination for Cause
. Notwithstanding anything herein to the contrary, if you are terminated from employment by the Company for Cause, then this Award will forfeit immediately as of the date of such termination.
|
|
(e)
|
No Further Obligation
. The Company will have no further obligations to you under this Award if the Award terminates as provided herein.
|
6.
|
Deferral of Performance Share Units
. If you are eligible to, and properly elect to, defer delivery of all or part of the Shares otherwise issuable under this Award, such deferral will be governed by the Performance Share Unit Deferral Election Form executed by you separately from this Agreement.
|
7.
|
Issuance of Shares
. The Company, or its transfer agent, will issue and deliver the Shares to you as soon as practicable after the Award vests (pursuant to the terms hereof) with respect to such Shares, or, if a deferral election was made, at the time specified in the Deferral Election Form. If you die before the Company has distributed the Shares due with respect to the vested Performance Share Units, the Company will issue the Shares to your estate or in accordance with applicable laws of descent and distribution. The Shares will be issued and delivered in book entry form, and the Company will not be liable for damages relating to any delays in making an appropriate book entry or any mistakes or errors in the making of the book entry; provided that the Company shall correct any errors caused by it. Any such book entry will be subject to such stop transfer orders and other restrictions as the Company may deem advisable under (a) the Plan and any agreement between you and the Company with respect to this Award or the Shares, (b) any applicable federal or state laws, and/or (c) the rules, regulations and other requirements of the Securities and Exchange Commission (“
SEC
”) of any stock exchange upon which the Shares are listed. The Company may cause an appropriate book entry notation to be made with respect to the Shares to reference any of the foregoing restrictions.
|
8.
|
Non-Transferability of Award
. Except as provided in the Plan, this Agreement and the Award Memorandum, until the Shares have been issued under this Award, this Award and the Shares issuable hereunder and the rights and privileges conferred hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (by operation of law or otherwise). Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this Award, or of any right or privilege conferred hereby, contrary to the provisions of the Plan or of this Agreement, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, this Award and the rights and privileges conferred hereby shall immediately become null and void.
|
9.
|
Conditions to Issuance of Shares
. The Shares issued to you hereunder may be either previously authorized but unissued shares or issued shares which have been reacquired by the Company. The Company shall not be required to issue any Shares hereunder prior to fulfillment of all of the following conditions: (a) the admission of such Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or under the rulings or regulations of the SEC or any other governmental regulatory body, which the compensation committee of the Board of Directors (the “
Compensation Committee
”) shall, in its discretion, deem necessary or advisable; (c) the obtaining of any approval or other clearance from any state or federal governmental agency, which the Compensation Committee shall, in its discretion, determine to be necessary or advisable; (d) the lapse of such reasonable period of time following the date of vesting of the Award or the payment event specified in a deferral election as the Compensation Committee may establish from time to time for reasons of administrative convenience (provided that any such period shall be in compliance with Code Section
|
10.
|
Dividends; No Rights as Shareholder
.
If the Company declares a cash dividend and the dividend record date occurs prior to the date the Award vests, you will be credited with an additional number of Target Units on the date the cash dividends are paid to the Company shareholders equal to (a) the amount of cash dividends payable with respect to a number of shares of stock equal to your Target Units divided by (b) the Fair Market Value of a Share on the date the dividend is paid. Until this Award vests and the Shares are issued to you, you shall have no rights as a shareholder of the Company with respect to the Shares. Specifically, you understand and agree that you do not have voting rights or, except as provided in this Section 10, the right to receive dividends or any other distributions paid with respect to shares of Company common stock by virtue of this Award or the Shares subject hereto.
|
11.
|
Addresses for Notices
. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company as follows: Corporate Secretary, Fiserv, Inc., 255 Fiserv Drive, Brookfield, WI 53045, or at such other address as the Company may hereafter designate in writing. Any notice to be given to you shall be addressed to you at the address set forth in the Company’s records from time to time.
|
12.
|
Captions; Agreement Severable
. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
|
13.
|
Securities and Tax Representations
.
|
(a)
|
You acknowledge receipt of the prospectus under the Registration Statement on Form S-8 with respect to the Plan filed by the Company with the SEC. You represent and agree that you will comply with all applicable laws and Company policies relating to the Plan, this Agreement and any disposition of Shares and that upon the acquisition of any Shares subject to this Award, you will make or enter into such written representations, warranties and agreements as the Company may reasonably request to comply with applicable securities laws or this Agreement.
|
(b)
|
You represent and warrant that you understand the federal, state and local income and employment tax consequences associated with the granting of the Award, the vesting of the Award, the deferral of all or a portion of the Shares otherwise issuable upon vesting of the Award, and the subsequent sale or other disposition of any Shares. You understand and agree that when this Award vests and Shares are issued, and you thereby realize gross income (if any) taxable as compensation in respect of such vesting or issuance, the Company will be required to withhold federal, state and local taxes on the full amount of the compensation income realized by you and may also be required to withhold other amounts as a result of such vesting. You hereby agree to provide the Company with cash funds or Shares equal in value to the federal, state and local payroll and income taxes and other amounts required to be withheld by the Company or its subsidiary in respect of any compensation income or wages in relation to the Award or make other arrangements satisfactory to the Company regarding such amounts, which may include deduction of such taxes from other wages owed to you by the Company or its subsidiaries. All matters with respect to the total amount to be withheld shall be determined by the Company in its sole discretion.
|
14.
|
Market Stand-Off
. The Company reserves the right to impose restrictions on dispositions in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended. Upon receipt of written notice from the Company of a trading restriction, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or
|
15.
|
General Provisions
.
|
|
(a)
|
None of the Plan, this Agreement or the Award Memorandum confers upon you any right to continue to be employed by the Company or any subsidiary of the Company or limits in any respect any right of the Company or any subsidiary of the Company to terminate your employment at any time, without liability.
|
|
(b)
|
This Agreement, the Award Memorandum, the Plan and the Restricted Stock Unit Deferral Election Form, if any, contain the entire agreement between the Company and you relating to the Award and the Shares and supersede all prior agreements or understandings relating thereto.
|
|
(c)
|
This Agreement and the Award Memorandum may only be modified, amended or cancelled as provided in the Plan.
|
|
(d)
|
If any one or more provisions of this Agreement or the Award Memorandum is found to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.
|
|
(e)
|
Any remedies available to the Company under the Plan or this Agreement are cumulative and are in addition to, and are not affected by, the other rights and remedies available to the Company under the Plan, this Agreement, by law or otherwise.
|
|
(f)
|
This Agreement and the Award Memorandum shall be governed by and construed in accordance with the laws of the State of Wisconsin, without regard to conflict of law provisions.
|
|
(g)
|
The Company agrees, and you agree, to be subject to and bound by all of the terms and conditions of the Plan. The Prospectus for the Plan is accessible on the Company’s administrative agent’s website in the “forms library” (www.netbenefits.fidelity.com) in the “forms library” and a paper copy is available upon request.
|
|
(h)
|
This Agreement and the Award Memorandum shall be binding upon and inure to the benefit of any successor or assign of the Company and to any heir, distributee, executor, administrator or legal representative entitled by law to your rights hereunder.
|
|
(i)
|
You understand that, under the terms of the Plan, this Agreement and the Award Memorandum, the Company may cancel or rescind this Award and/or the Shares in certain circumstances.
|
•
|
You will participate in our annual cash incentive plan with an annual bonus target of $587,000 (115% of your base compensation) and a maximum payout of $1,174,000 (230% of base salary) in each year.
|
•
|
Your bonus payout will vary based upon the achievement of designated criteria annually which may include, but not be limited to, overall company performance, specific business performance, individual performance and personal leadership performance.
|
•
|
Bonus awards as earned will be paid no later than March 15 of the year following the calendar period.
|
•
|
You must be employed by the Company on the payment date to receive an ACIP payout for the prior year.
|
•
|
You will be eligible to participate in our long-term equity plan (AEIP) which is a wealth building program for senior executives designed to reward and compensate you for long-term performance, and align your rewards with those of our shareholders.
|
•
|
Your base annual equity target will be $1,000,000 which will be delivered in the form of Restricted Stock Units, Stock Options and/or Performance Shares. Vesting will occur over a three-to-four year period depending upon the underlying equity instrument(s) delivered. Your equity award will also vary each year based on your performance, that of the Company, and other criteria as determined by the Board of Directors from time to time. Equity awards are subject to increases and decreases in value based on the share price at the time the award is made and/or vests.
|
•
|
You will be eligible for your first annual award in February 2017 which may be pro-rated depending upon your actual start date.
|
•
|
The award amount actually earned each year will vary based on the assessment of your performance as recommended by the CEO and approved by the Fiserv Board of Directors.
|
•
|
$1.0 million of the sign-on equity will be Restricted Stock Units (RSU) which will vest equally on the third and fourth anniversary of your start date.
|
•
|
$2.2 million of the sign-on equity will be Non-Qualified Stock Options which will vest equally on the third and fourth anniversary of your start date.
|
•
|
Associates may contribute from one to fifty percent of their compensation to the plan on a pre-tax basis depending upon personal circumstances.
|
•
|
The company match is immediate and contributed on a per-pay period basis.
|
•
|
You are 100% vested in the money you defer into the 401(k) plan. The matching contributions from Fiserv will vest after you have accrued two years of service.
|
•
|
You can purchase Fiserv stock at a 15% discount to the closing price on the last trading day in the quarter through after-tax payroll deductions.
|
•
|
You can contribute from one to ten percent of your base salary up to the allowable IRS maximum.
|
•
|
Stock is purchased quarterly and deposited into a personal account administered by Fidelity Investments.
|
/s/ Devin B. McGranahan
|
|
8-2-16
|
Devin McGranahan
|
|
Date
|
/s/ Jeffery W. Yabuki
|
|
10/31/2016
|
Jeffery W. Yabuki
|
|
Date
|
FISERV, INC.
|
||
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jeffery W. Yabuki
|
|
|
Jeffery W. Yabuki
|
|
|
President and CEO
|
|
|
|
|
|
|
|
|
|
|
|
|
EXECUTIVE:
|
||
|
|
|
|
|
|
/s/ Devin B. McGranahan
|
||
Devin B. McGranahan
|
||
|
|
|
If to the Company:
|
Fiserv, Inc.
|
|
Vice President, Compensation & Benefits
|
|
255 Fiserv Drive
|
|
Brookfield, WI 53045
|
|
|
If to a Participant:
|
To the address designated by Participant to the
|
|
Company as most recently on file in the Company’s
|
|
personnel records.
|
FISERV, INC.
|
|
||
|
|
|
|
By:
|
|
/s/ Jeffery W. Yabuki
|
|
|
|
Name:
|
Jeffery W. Yabuki
|
|
|
Title:
|
President & Chief Executive Officer
|
|
|
|
|
|
|
|
Name under which Subsidiary does Business
|
|
State (Country) of Incorporation
|
BillMatrix Corporation
|
|
Delaware
|
Carreker Corporation
|
|
Delaware
|
CheckFree Corporation
|
|
Delaware
|
CheckFree Services Corporation
|
|
Delaware
|
CheckFree Solutions Limited
|
|
United Kingdom
|
CheckFreePay Corporation
|
|
Connecticut
|
Corillian Corporation
|
|
Oregon
|
Fiserv Automotive Solutions, Inc.
|
|
Delaware
|
Fiserv CIR, LLC
|
|
Delaware
|
Fiserv (Europe) Limited
|
|
United Kingdom
|
Fiserv Global Services, Inc.
|
|
Delaware
|
Fiserv Investment Solutions, Inc.
|
|
Delaware
|
Fiserv PAR, Inc.
|
|
Wisconsin
|
Fiserv Solutions, LLC
|
|
Wisconsin
|
Information Technology, Inc.
|
|
Nebraska
|
ITI of Nebraska, Inc.
|
|
Nebraska
|
Open Solutions, LLC
|
|
Delaware
|
XP Systems Corporation
|
|
Minnesota
|
1.
|
I have reviewed this Annual Report on Form 10-K of Fiserv, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
|
|
Date:
|
February 23, 2017
|
By:
|
/s/ Jeffery W. Yabuki
|
|
|
|
|
Jeffery W. Yabuki
|
|
|
|
|
President and Chief Executive Officer
|
|
1.
|
I have reviewed this Annual Report on Form 10-K of Fiserv, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
|
|
|
Date:
|
February 23, 2017
|
By:
|
/s/ Robert W. Hau
|
|
|
|
|
Robert W. Hau
|
|
|
|
|
Chief Financial Officer and Treasurer
|
|
(1)
|
The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
By:
|
/s/ Jeffery W. Yabuki
|
|
|
Jeffery W. Yabuki
|
|
|
President and Chief Executive Officer
|
|
|
February 23, 2017
|
|
|
|
|
By:
|
/s/ Robert W. Hau
|
|
|
Robert W. Hau
|
|
|
Chief Financial Officer and Treasurer
|
|
|
February 23, 2017
|